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ABSTRACT
LIPID BILAYER PERMEATION OF AN ALIPHATIC AMINE DRUG: MODELING
WITH MOLECULAR DYNAMICS SIMULATIONS AND KINETIC RATE
EQUATIONS
TUG˘C¸E ORUC¸
M.Sc. Thesis, June 2016
Supervisor: Asst. Prof. Dr. Deniz Sezer
Keywords: Aliphatic amines, drug permeation, lipid bilayer, molecular dynamics
simulations, kinetic modeling
Aliphatic amine bearing drugs constitute about 27% of all orally active drugs. Since
they comprise a large proportion, it is important to understand their permeation mecha-
nism through cell membrane. In this thesis, the permeation of an aliphatic amine drug
through a lipid bilayer is treated at three different levels of spatio-temporal resolution. On
the finest scale, the interactions of the aliphatic amine drug dyclonine with the lipid bi-
layer are modeled in atomistic detail via molecular dynamics (MD) simulations. Because
the aliphatic amine group is ionizable it can be in either positively charged or neutral. MD
simulations reveal that both charge states penetrate into the bilayer and the neutral drugs
easily translocate. However, complete permeation events are not observed. To understand
the mechanism of permeation, therefore, a coarser model of one-dimensional diffusion in
a potential is employed. To apply the model, diffusivity and free energy profiles along
bilayer normal are obtained via MD simulations. The resulting hydrodynamic description
of the permeation allows access to longer time scales and provides the calculation of the
permeability coefficients. Finally, on the coarsest level, we model the drug permeation
into liposomes via kinetic rate equations. The model reproduces recent experiments that
measure the permeability coefficients of aliphatic amine drugs using pH-sensitive fluo-
rophores. We observe that while the experimental assay is sensitive to the protonation
rate of the drug, it is basically insensitive to the drug permeability. The multiscale model-
ing strategy employed here is very general and can be straightforwardly applied to other
titratable drug molecules.
iv
O¨ZET
ALI˙FATI˙K AMI˙N I˙LACIN LI˙PI˙T I˙KI˙LI˙ KATMANINDAN GEC¸I˙S¸I˙: MOLEKU¨LER
DI˙NAMI˙K SI˙MU¨LASYONLARI VE KI˙NETI˙K HIZ DENKLEMLERI˙ I˙LE
MODELLENMESI˙
TUG˘C¸E ORUC¸
Yu¨ksek Lisans Tezi, Haziran 2016
Danıs¸man: Yard. Doc¸. Dr. Deniz Sezer
Anahtar kelimeler: Alifatik aminler, ilac¸ gec¸is¸i, lipit ikili katmanı, moleku¨ler dinamik
simu¨lasyonları, kinetik modelleme
Alifatik amin ic¸eren ilac¸lar oral ilac¸ların %27’sini olus¸turmaktadır. Bu¨yu¨k bir yu¨zdeye
sahip oldukları ic¸in bu ilac¸ların hu¨cre zarından gec¸is¸ mekanizmasını anlamak o¨nemlidir.
Bu tezde, alifatik amin ic¸eren bir ilacın lipit ikili katmanından gec¸is¸i u¨c¸ farklı uzamsal
ve zamansal seviyelerde incelenmis¸tir. En ku¨c¸u¨k o¨lc¸ekte, alifatik amin ilacın -dikloninin-
lipit ikili katmanıyla olan ilis¸kisi moleku¨ler dinamik (MD) simu¨lasyonlarıyla atomik de-
tayda modellenmis¸tir. Alifatik amin grubu iyonlas¸abildig˘i ic¸in ilac¸ pozitif yu¨klu¨ ya da
no¨tr olabilir. Her iki yu¨k durumunda da ilac¸ların ikili katmana girebildig˘i ve no¨tr ilacın
kolaylıkla katman deg˘is¸tirebildig˘i MD simu¨lasyonları ile go¨sterilmis¸tir. Ancak, gec¸is¸
olayının tamamı go¨zlemlenmemis¸tir. Gec¸is¸ mekanizmasını anlamak ic¸in daha genis¸ o¨lc¸ekli,
potansiyel ic¸inde bir boyutlu difu¨zyon modeli kullanılmıs¸tır. Bu modeli uygulayabilmek
ic¸in lipit ikili katmanı normali boyunca difu¨zyon ve serbest enerji profilleri MD simu¨lasyon-
ları ile olus¸turulmus¸tur. Gec¸is¸ mekanizmasının hidrodinamik ac¸ıklaması daha uzun za-
manlı olayların elde edilmesini ve gec¸is¸ sabitlerinin hesaplanmasını sag˘lamıs¸tır. Son
olarak, en kapsamlı boyutta, kinetik hız denklemleri ile lipozomlara ilac¸ gec¸is¸i modellen-
mis¸tir. Bu c¸alıs¸ma ile yakın zamanda gerc¸ekles¸tirilmis¸, pH deg˘is¸imine hassas floroforlar
kullanılarak lipozomlara alifatik amin gec¸is¸ini o¨lc¸en deneyler modellenmis¸tir. Bu model
ile deneysel sistemin ilacın proton alma hızına hassas oldug˘unu, ilac¸ gec¸is¸ine ise duyarsız
oldug˘unu go¨zlemlemekteyiz. Bu c¸alıs¸mada uygulanan c¸ok o¨lc¸ekli modelleme stratejisi
oldukc¸a geneldir ve dig˘er iyonlas¸abilen ilac¸lar ic¸in kolay bir s¸ekilde uygulanabilir.
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Chapter 1
Introduction and Motivation
1.1 Drugs and Synergy
1.1.1 Measurement of Drug Efficacy
Drugs can be defined as chemical substances that have any effect on any living organism.
In medicine, they are used for many purposes including diagnosis, treatment and cure of
a disease. The number of drugs increases day by day and the total amount of drugs as of
May 2016 is 8206 [1].
Drugs should have an effect on the phenotype of a selected organism. For unicellular
organisms, a measure of the effect of a drug can be the change in the growth curve of
the organism. The growth curve shows how the number of cells in a population changes
over time. In the case of cells that grow in an aqueous environment, the concentration
of cells in a given compartment can be measured by monitoring the optical density (OD)
of the solution. As it is seen in the first box of Figure 1.1, OD600 value (optical density,
the measure of the concentration of the cells) changes over time. Here, we see how the
concentration of Saccharomyces cerevisiae is changed in 18 hours. In approximately first
ten hours no increase in the curve is observed which is called lag phase. Afterwards, the
OD600 value increases indicating that the population of cells grows steadily. This phase
is either called logarithmic (log) or exponential phase. Finally, the concentration of the
cells reaches a stationary phase which is barely seen in the figure. Drugs may exhibit their
impact by affecting any of these phases, or more than one phase simultaneously.
For example, the drug dyclonine has an effect on yeast cells through targeting an
ergosterol pathway protein Erg2 [2]. This effect can be observed in yeast cells in a dose-
dependent manner. Figure 1.1 shows the results of the experiments that I conducted by
subjecting yeast cells to increasing doses of dyclonine. How yeast populations respond to
linearly increased dosage of dyclonine (dyc) is seen in the figure. While in the first box,
no drug was given to the yeast cells, in the last box the minimum inhibitory concentration
(MIC) of the drug was applied. As the concentration of the drug increases, the lag time
1
of the growth curves elongates. Therefore we can conclude that dyclonine affects the lag
phase in a dose-dependent manner. For simplicity, let me define the “growth” as the total
area under the growth curve. For larger drug concentrations the area under the growth
curve decreases.
Meanwhile, we were ought to see maximum effect in the 7x concentration that corre-
sponds to minimum inhibitory concentration (MIC, which corresponds to 50 µM in this
case) in which no growth should be detected. However, there must be an experimental
error resulting an increase in the concentration of the cells.
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Figure 1.1: Growth curves of yeast cells in the presence of dyclonine with linearly in-
creased dosage (from left to right) is shown. Increase in dosage of dyclonine cause a
decrease in the “growth” of the yeast cells. At first box, no drug was applied to cells and
at last box (7x) minimum inhibitory concentration of drug was applied.
Pentamidine offers another example of a drug which is effective on yeast cells. Fig-
ure 1.2 shows the results of the experiments that I conducted by subjecting yeast cells to
increasing doses of pentamidine. We again see that as the concentration of the drug in-
creases (from no drug to MIC which is 100 µM in this case), the slope of the exponential
growth phase decreases. Since this slope is related to the growth rate we can conclude that
pentamidine affects the growth rate in a dose-dependent manner; namely as the dosage of
the drug increases, the growth rate of the cell decreases.
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Figure 1.2: Growth curves of yeast cells in the presence of pentamidine with linearly
increased dosage (from left to right) is shown. Increase in dosage of pentamidine cause a
decrease in the “growth” of the yeast cells. At first box, no drug was applied to cells and
at last box (7x) minimum inhibitory concentration of drug was applied.
Note that dyclonine and pentamidine are just two of the drugs in the market. Actually,
there are enormous number of drugs and it is never sufficient to cure all diseases. While
constitution of new therapeutic drugs is a way to obtain more effective results in treat-
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ment, combining current drugs to obtain synergistic outcomes is another possibility that
is extensively studied in pharmaceutical research [3].
1.1.2 Measurement of Drug Synergy
If the combination of at least two drugs shows an effect that is “better” than their individ-
ual outcome, then these drugs are called synergistic. For instance, in Figure 1.1 we see
maximum effect (minimum growth) of dyclonine in the 7th box and in Figure 1.2 we see
maximum effect (minimum growth) in 8th box, which means in order to see the effects
of drugs we should use at least 6x and 7x concentrations, respectively. When these two
drugs are used together if we see less growth than their individual maximum effect, then
these two drugs are called synergistic. In Figure 1.3, results of an interaction experiment
of dyclonine and pentamidine is shown. This experiment was performed in order to see
whether these two drugs are synergistic or not. In horizontal axis dosage of dyclonine,
in vertical axis dosage of pentamidine were increased. At the bottom left corner, no drug
was applied to the cells.
dyclonine !
pe
nt
am
id
in
e 
!
Figure 1.3: Interaction experiment was performed for dyclonine and pentamidine in order
to determine the synergistic effects of the drugs. In horizontal axis, concentration of
dyclonine was linearly increased and in vertical axis, concentration of pentamidine was
linearly increased. Red circle shows the box in which 2x concentrations of each drugs are
present.
Lets focus to the box in which 2x of both drugs were treated. It is shown in the red
circle of Figure 1.3. It is seen that in that box “growth” of the cells are clearly less than 7x
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dosage of pentamidine and slightly lower than 6x dosage of dyclonine. Note that in that
well there is 4x dosage of drug in total which is less than individual dosages of dyclonine
and pentamidine 6x and 7x, respectively. Therefore, as less dosage of drugs in total is
more “effective” than individual dosages, these drugs (dyclonine and pentamidine) are
synergistic with each other.
One important advantage of drug synergy is the fact that side effects of the synergistic
drugs do not show synergy usually. Therefore, revealing new drug pairs and understand-
ing the mechanism of the synergy has become a widely studied area. [3].
1.1.3 Systematic Exploration of Pairwise Drug Synergies
As drug synergy is vital for new treatments, systematic investigation of synergistic drug
pairs constitutes an important research area. Cokol et al. studied whether a set of drugs
(including dyclonine and pentamidine) have synergistic interactions with each other on
the yeast cells. In Figure 1.4, at left panel we see results of interaction experiments.
Note that each interaction experiment has 8ˆ8 matrix which actually represent Figure
1.3 like matrix in colormap view. White boxes indicate maximum growth which scales
down via shades of red to black boxes which means no growth. As a result, they indicate
synergistic pairs with a green “S”. Note that there are red “A” in some boxes which
indicates antagonistic interaction of corresponding drug pairs. Antagonistic drugs repress
each others activity on the contrary of synergy. It is seen that pentamidine and terbinafine
have the maximum number of pairs. In the right panel of the same figure drugs are
connected to each other based on their interaction type. Importance of “promiscuous
synergizers” will be discussed in the following section.
Figure 1.4: (A) Growth of yeast with different drug exposure increasing to minimum
inhibitory concentration of each drug. S and A indicate synergistic and antagonistic inter-
action, respectively. Green squares shows the drug pairs which target proteins expressed
by synergistic genes. (B) Interaction of drug pairs. Green and red lines show synergy and
antagonism respectively. “Promiscuous synergizers” are shown in rectangle which have
highest number of synergistic pairs. Figure is taken from Ref. [3].
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1.1.4 Mechanism of Synergy
Different proteins on different pathways may be responsible for a specific phenotype in
living organisms. These related pathways are called parallel pathways. If two drugs target
two different proteins in these parallel pathways, then synergistic effect on the phenotype
can be observed. This is one possible mechanism of synergy. In that case these genes
encoding the targeted proteins have synergistic genetic interaction.
Another possible mechanism for drug synergy is that a drug can increase the bioavail-
ability of another drug which results synergism.
Cokol et al., have tested drugs which target parallel pathways that have synergistic
genetic interactions. Each drug targets a different protein in a known synergistic genetic
interaction (with an exception of ergosterol pathway). As a result, they observed that all
interactions cannot be explained via synergistic genetic interaction especially for the ones
grouped as “promiscuous synergizers”. In addition to experiments performed with these
dataset, more experiments were conducted for pen, ter and tac with drugs whose targets do
not have genetic interactions with their targets. Results supported the promiscuity of the
aforementioned drugs which reinforced the idea that synergistic interactions for promis-
cuous synergizers are caused by some other reason rather than genetic interactions of the
targeted proteins [3]. This situation raises the possibility of increment of bioavailability
mechanism.
One of the possible ways to increase the bioavailability of a drug is to ease its per-
meation through the cell membrane which leads an elevation in the number of drugs that
can reach their target inside of the cell. Therefore one possible bioavailability mechanism
for drug synergy is the situation in which two drugs may “help” each other while passing
through cellular membrane.
The ability of permeation of a drug though lipid bilayer actually depends on its physic-
ochemical properties rather than its biological activities.
1.2 Physicochemical Properties of Drugs
For a drug to be able to penetrate into the bilayer, first it should have a tendency to localize
in hydrophobic environment. The measure of this tendency is the lipophilicity of the drug
which is basically lipid-likeness. Lipid-likeness of a molecule is measured by the partition
coefficient which is determined as
P “ rDrugsoctanolrDrugswater , (1.1)
when the drug is in its neutral state.
For drug-likeness, lipophilicity of a compound should be in a critical range. For ex-
ample, according to Lipinski’s rule of five (which is widely accepted approach in deter-
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mination of drug-likeness), logP (base 10 logarithm of the partition coefficient) values
should be smaller than five [4]. Another study that has classified drugs based on their
logP values, indicates distribution gives the peak at around logP = 2.5-3 [5].
Meanwhile, in another study of Cokol group, they show that synergicity and lipophilic-
ity are positively correlated [6]. It is seen that besides being a determinant factor in drug-
likeness, lipophilicity is also important in other properties like synergy.
Recent study performed by Manallack et al. analyzed the charged states of the drugs
[7] classified them based on their ionizability as it is shown in Figure 1.5. Results showed
that single basic drugs comprise the highest proportion, 27.8%, of all drugs (note that this
is even larger than proportion of the neutral drugs). Besides, single acidic drugs have a
portion of 14.2%. Additionally, always ionized groups are only 6.3% of all drugs.
Figure 1.5: single drugs have the highest proportion which is even larger than neutral
drugs. Single acidic drugs have also large proportion which is slightly smaller than neutral
drugs. Meanwhile always ionized drugs have second smallest proportion. These ratios
suggest that bearing a charged group is a preferred condition. Figure is taken from Ref.
[7].
In addition to classification of the drugs based on their charged state, they also an-
alyzed and discriminated the drugs depending on the type of functional groups. They
noticed that among all functional groups aliphatic amines comprise the ratio of 27.1%
and the ratio of carboxylic acids is 20.1%. Among aliphatic amines, the proportion of
tertiary amines is 49% [8]. On the other hand, same research group also scanned non-
drug small compounds and performed same classification for these compounds. They
showed that aliphatic amine ratio is only 3.4% among non-drug substances, similarly ra-
tio of carboxylic acids is only 2.4% [7]. These results emphasize two points: (i) single
ionizable group bearing drugs constitute more than half of the drugs, (ii) among these ion-
izable groups some functional groups are more abundant (aliphatic amines for basic drugs
and carboxylic acids for acidic drugs) and having these ionizable groups is a determinant
factor to be a drug or not.
Note that while bearing a charged group is an advantage for a molecule to be a drug,
having it permanently is not a preferred condition (since their ratio is only 6.3%). Besides
the probability of affecting other properties like distribution and metabolism, having per-
manent charge may reduce the success of permeation through lipid bilayer since ionic
6
components need to overcome a high energy barrier. This situation brings pKa of drugs
into the stage. pKa, acid dissociation constant, can be described as
AH
KaÝáâÝ A´ ` H`, (1.2)
where AH is an acidic substance with dissociation constant, Ka in which
Ka “ rA
´srH`s
rAHs . (1.3)
As we take logarithm of both sides on base 10,
log10pKaq “ log10 rA
´s
rAHs ` log10rH
`s. (1.4)
Since pH is ´ log10rH`s and pKa is ´ log10pKaq,
pKa “ ´ log10 rA
´s
rAHs ` pH. (1.5)
Therefore, the ratio of two charged state of a compound can be denoted as,
rA´s
rAHs “ 10
pH´pKa . (1.6)
Similarly for a basic substance,
rB`s
rBHs “ 10
pKa´pH. (1.7)
In other words, pKa is a decisive property for charged state and abundance of the state
in a certain environment (specific pH). In the same study, Manallack et al. also evaluated
the pKa of single basic and single acidic drugs [7]. They report that more than half of the
basic drugs have pKa between 8-10 and approximately half of the acidic drugs have pKa
between 3-5.
When we analyze the structure of the drugs that are synergistic pair with pentamidine,
we see that most of them bear an aliphatic amine group.
1.3 Scope of the Thesis
As all synergistic pairs of pentamidine have aliphatic amine group, understanding the
mechanism of how aliphatic amine bearing drugs permeate through lipid bilayer is a in-
triguing issue. Since aliphatic amines comprise substantially high proportion of drugs
based on their functional groups, studying dyclonine which is an ionizable tertiary aliphatic
amine bearing drug with pKa 8.4, logP 3.68 [9] may provide an explanation for perme-
ation mechanism of most of the drugs.
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As dyclonine has an ionizable amine it can be in both charged and neutral states de-
pending on the pH of the environment.
Figure 1.6: Dyclonine molecules can be both neutral and charged states. Aliphatic amine
ring is shown in green circle. Circled group is defined as “head group” and the rest is
defined as the “tail” of the molecule.
Dyclonine has different targets in different organisms. It was shown that dyclonine has
antibacterial and antifungal effects [10]. Moreover, dyclonine is used as local anesthetic
since it diffuses across the bilayer and binds to the inner pore of ion channels, resulting
in inhibition of ion transport of nerve cells [11]. Note that the permeation mechanism
of local anesthetics through the lipid bilayer is another area that is widely studied both
experimentally and computationally [12, 13, 14, 15].
In this research it was aimed to understand the permeation mechanism of dyclonine
through lipid bilayer via molecular dynamics simulations. For this purpose, characteris-
tic behaviors of dyclonine - lipid interactions and permeation process with “three-layer”
perspective are studied for both charge states of the molecule. Additionally, an experi-
mental method which is used to determine permeability coefficients of drugs is modeled
via kinetic rate equations with an increasing complexity.
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Chapter 2
Dyclonine - Lipid Bilayer Interactions:
Molecular Dynamics Simulations
2.1 Methods
2.1.1 Parametrization of Dyclonine
To perform molecular dynamics (MD) simulations of dyclonine it is necessary to con-
struct force field parameters for both the neutral and charged states of the molecule (Figure
1.6). We first constructed the neutral state and achieved charged state by simply adding
hydrogen atom. Therefore building neutral state is explained in detail in this section. In
order to obtain three dimensional structure of dyclonine, energy parameters of neutral
state was determined by splitting the molecule into two fragments as it is shown in Figure
2.1.
Topology files were constructed for two fragments separately. Initial parameters of
the fragments and partial charges of atoms were determined via using similar structures
which are already found in the Charmm36 force field ([16, 17, 18]). Since this led us
to determine most of the parameters but not all, ab initio calculations were performed to
determine the correct configurations of both fragments. By using Gaussian software [19]
one dihedral angle (Figure 2.1 atoms of CA, ND, CM2 and CM1 -χ1- of fragment 1 and
two dihedral angles (Figure 2.1 atoms of CG CX CM1 CM2 and CD1 CG CX CM1 -χ2
and χ3 of fragment 2 were scanned with 15 degree intervals. Resulting energy values of
corresponding dihedral angles were obtained by adjustment of parameters with structural
and vibrational analysis.
In Figure 2.2, we see the energy values of conformations with corresponding dihedral
angles for the fragment 1. It is seen that energy profile of conformations constructed
by adjustment of parameters by Charmm (black) is highly similar to the energy profile
obtained by Gaussian (red). This shows that determined energy parameters of Charmm
are successful enough as it mimics ab initio calculations. In the figure, we see there is
9
Figure 2.1: Determination of three dimensional structure was performed by splitting the
molecule into two fragments. In fragment 1 one dihedral angle, χ1, and in fragment 1 two
dihedral angles, χ2 and χ3 are scanned with 15˝ intervals.
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Figure 2.2: Energy profiles for fragment 1 is shown with respect to dihedral angle of
dihedral χ1. Energy values are determined via Gaussian (red) and Charmm (black) after
adjustment of energy parameters are shown.
three local minima whose corresponding dihedral angles (which are ´70˝, 70˝ and 165˝)
provide preferred conformations. Dihedral angles of ´70 and 70 were selected for initial
conformations of this fragment.
Similarly, in Figure 2.3, we see the energy values for fragment 2 that were obtained
via Gaussian (red) and by adjusting charmm parameters (black). Since local minimum
values are located at where dihedral χ3 is either 0˝ or 180˝ and χ2 is 180˝, these dihedral
angles were selected for initial conformations of fragment 2.
Eventually, we ended up with four conformations (Figure 2.4). Dihedral angles of
each conformation is given in Table 2.1.
χ1 χ2 χ3
C1 70˝ 180˝ 180˝
C2 -70˝ 180˝ 180˝
C3 70˝ 180˝ 0˝
C4 -70˝ 180˝ 0˝
Table 2.1: Dihedral angles of dyclonine’s four conformations.
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Figure 2.3: Energy profiles for fragment 2 is shown with respect to dihedrals χ2 and χ3.
Energy values are determined via Gaussian (red) and Charmm (black) after adjustment of
energy parameters are shown.
Figure 2.4: After determination of energy parameters of both fragments, we ended up
four different configurations of dyclonine.
Preliminary analysis of dihedrals of χ1, χ2 and χ3 for 10 ns simulations are shown in
Figure 2.5. C1, C2, C3 and C4 are shown with blue, green, cyan and red, respectively. For
fragment 1, it is seen that dihedral χ1 does not stick to initial angle and except ´50˝ - 50˝
interval, it can span all angles. Surprisingly, even though the energy barrier around´135˝
is high, dihedral can span this angle. On the contrary, dihedrals χ2 and χ3 of fragment 2
are not free to span all angles. While angle of χ2 can reach ´90˝ and 90˝, χ3 seem to be
restricted within its initial dihedral angles.
2.1.2 Construction of Pure Lipid Bilayer
In order to build lipid bilayer, charmm-gui [20] was used. Dipalmitoylphosphatidyl-
choline (DPPC) was selected as model phospholipid which is widely used in molecular
dynamics (MD) simulations. Model bilayer was composed of total 128 DPPC in which
64 of them were located at upper leaflet and 64 at the lower leaflet. The initial system
11
 time (ns)
0 2 4 6 8 10
 
Fr
ag
m
en
t 1
 d
ih
ed
ra
l 
@ 1
-180
-135
-90
-45
0
45
90
135
180
 Fragment 2 dihedral @2
-180 -135 -90 -45 0 45 90 135 180
 
Fr
ag
m
en
t 2
 d
ih
ed
ra
l 
@ 3
-180
-135
-90
-45
0
45
90
135
180
Figure 2.5: Dihedral χ1 of fragment 1 is successful in spanning all the dihedral angles ex-
cept ´50˝ - 50˝ interval where the energy barrier reaches 6 kcal/mol in 10 ns simulations
(left). Dihedrals χ2 and χ3 are less capable of span larger intervals. While χ2 can change
up to ´90˝ and 90˝, χ3 is restricted to initial values in 10 ns simulations.
included 7131 water molecules. Additionally 0.15 mM KCl ion was added which corre-
sponded to 22 K` and 22 Cl´ ions. We used hexagonal simulation box with dimensions
of approximately 6.8 nm ˆ 6.8 nm ˆ 9.5 nm.
First, the system was equilibrated with the methodology as it was recommended by
charmm-gui. During this equilibration, lipids were slowly released from constraints for
stability of the bilayer structure consistent with experimental studies. Constructed system
was simulated for 13 ns. For all systems CHARMM36 force field was used with TIP3P
water. Simulations were performed with NAMD [21]. Particle-mesh Ewald method was
used to calculate electrostatic interactions, SHAKE algorithm was used to constrain the
bond of hydrogen atoms. Pressure was set to 1 atm by Langevin piston and temperature
was set to 323.15 K which is above of gel phase and provides perfect agreement between
experimental and simulation studies for DPPC via Nose - Hoover thermostat [18]. Peri-
odic boundaries were opened for continuity of the system.
2.2 Results
2.2.1 Charged Dyclonine
Modifications of system were performed on the last frame of 13 ns pure bilayer simula-
tion. Eight charged dyclonine molecules were inserted into the aqueous environment of
the simulation box in order to understand how they start to interact with the lipid bilayer.
They were located at a distance of approximately 3 nm from the center of the bilayer
(four of them were above and four of them below of the bilayer as shown in Figure 2.6).
Two of each conformation of dyclonine were used. Water molecules overlapping with the
inserted drug molecules were removed from the system. Four K` atoms were deleted and
additional four Cl´ atoms were added in order to neutralize final system. Resulting sys-
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tem included 128 DPPC, 18 K`, 26 Cl´, 7003 water, and 8 drug molecules (8D` system).
Simulation lasted for 250ns.
Initial and final configurations of the molecules are shown in Figure 2.6. In the illustra-
tion red, cyan, blue, brown, white colors represent oxygen, carbon, nitrogen, phosphorous
and hydrogen atoms, respectively. Therefore small red dots indicate water molecules,
cyan lines show carbon tails of lipid bilayer, brown balls show phosphorous atoms of
lipid head, blue dots indicate nitrogen atoms of choline group of lipid head. It is seen that
within 250 ns all eight dyclonine molecules have inserted themselves into the membrane.
Figure 2.6: Eight charged dyclonine outside of the bilayer was simulated for 250 ns.
All molecules are capable of penetrating into bilayer within simulation time. Red, cyan,
blue, brown, white colors represent oxygen, carbon, nitrogen, phosphorous and hydrogen
atoms, respectively.
In order to visualize charged dyclonine molecules’ motion in the simulation box, time
trace of eight molecules were drawn. Head groups of dyclonine molecules were se-
lected to visualize their motion. We define membrane border with phosphorous atoms
which are shown with brown and each configuration of dyclonine is shown with differ-
ent color. In Figure 2.7A, we see that all penetration events are completed before 150
ns. In Figure 2.7B, position distributions of drugs, phosphorous atoms, lipid tail and wa-
ter molecules are shown with black, brown, cyan and red, respectively. It is seen that
dyclonine molecules locate at just below of phosphorous atoms in the bilayer. Addition-
ally, drugs never change leaflet and they do not even enter into hydrophobic core of the
membrane.
Inspection of the MD trajectories reveals that to enter into the bilayer the charged
dyclonine molecules need to insert their tails first. One such insertion is shown in Fig-
ure 2.8 which is completed in 2 ns. Otherwise, when they approach to bilayer with their
head groups they are unable to penetrate into bilayer. In Figure 2.7, one of the dyclo-
nine molecules at upper leaflet, shown with red color around 50th ns, approaches to the
13
Figure 2.7: Time trace of eight charged dyclonine molecules (A) and their position dis-
tribution within the simulation box (B) are shown. Dyclonine molecules prefers to locate
slightly below of the phosphorous atoms of the lipids.
bilayer with its head group (Figure 2.9). As it first introduces its head group into bilayer
it is unable complete entrance into membrane. The molecule remains in this position for
approximately 10 ns and then leaves the bilayer.
Figure 2.8: Dyclonine molecule should first introduce its tail into bilayer in order to
complete insertion process. The insertion is completed in 2 ns. The color of interested
dyclonine is shown opaque while other dyclonine molecules are shown metallic.
In addition, while dyclonine molecules move freely in aqueous environment, it is seen
that when they penetrate into the bilayer they prefer to stay parallel to the bilayer normal.
In order to determine their orientation quantitatively, we define a vector from tail (CG1,
CK1, CK2 and CK3) to aliphatic ring (atoms of ND, CA, CB, CC, CD, CE and CM2) of
the molecule and determine the angle of the vector with normal of the bilayer in positive
direction (`z direction) as it is shown in Figure 2.10. In Figure 2.11 orientation of eight
dyclonines are shown separately. It is seen that four of the molecules stay around z =
2 nm with 0˝ indicating they reside their tails in ´z direction and similarly, other four
molecules which stay around z = -2 nm orient their tails in `z direction resulting the
angle of 180˝.
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Figure 2.9: Dyclonine molecule fails to enter into bilayer since it first introduces its head
group into bilayer. The shown process last approximately 10 ns. The color of interested
dyclonine is shown opaque while other dyclonine molecules are shown metallic.
Figure 2.10: In order to determine the orientation of the molecules a vector is defined
from tail (CG1, CK1, CK2 and CK3) to aliphatic ring of the molecule, and the angle of
this vector with positive z direction is taken as θ.
2.2.2 Neutral Dyclonine
In addition to understanding the behavior of charged dyclonine, we aimed to figure out
dyclonine behavior when it interacts with lipid bilayer in neutral state. Eight neutral dy-
clonine molecules were inserted into the system, again approximately 3 nm away from
the bilayer center (Figure 2.12A) after 13 ns pure bilayer simulation. As before, each
conformation of dyclonine was used twice. After inserting the molecules into the simula-
tion box, overlapping water molecules were removed and resulting system included 128
DPPC, 22 K`, 22 Cl´ and 7006 water molecules (8D0). System was simulated for 250
ns.
At pH = 6.5 (pH of yeast experiments), number of neutral dyclonine compared to
charged dyclonine should be approximately 80 (10ppKa´pHq, pKa “ 8.4) times less than
charged ones. Therefore, equal amount of charged and neutral dyclonine in aqueous
environment is not experimentally realistic. However, as we can simulate any theoretical
conditions with molecular dynamics simulations, we used the same amount of neutral
dyclonine.
During 250 ns simulation, just one of the molecules was able to insert itself into
the membrane (Figure 2.12B). Last snapshot of the simulation shows that other seven
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Figure 2.11: Charged dyclonine molecules stay parallel to normal of bilayer. The ones
enter into the bilayer (bilayer borders are shown with brown lines) from upper leaflet
stays with an angle 0˝ and the ones enter into bilayer from lower leaflet stays with an
angle 180˝. Cut-off selection for visualization allows to show orientation distribution of
molecules in the water for just four dyclonine molecules while all molecules have the
same distribution pattern in the water.
molecules stay together in water.
Time traces of neutral molecules were also analyzed. In Figure 2.13A, we see that
only one of the dyclonine molecules enters into the bilayer while remaining ones stay in
aqueous environment throughout 250 ns simulation. Position distributions are shown in
Figure 2.13B. It is seen that the molecule which is capable of entering into lipid bilayer
has changed lipid leaflet several times.
Similar with charged dyclonine, neutral one also insert its tail first (Figure 2.14). Since
we have have only one event for this process, it is difficult generalize this behavior for all
neutral dyclonine molecules.
When we analyze orientation of neutral dyclonine molecules we see that the ones stay
at outside of the bilayer can be in any orientation, as expected (Figure 2.15). For the
one which is capable of entering into lipid bilayer, we can indicate it slightly prefers to be
parallel to lipid bilayer normal when it is closer to head groups and changes its orientation
while changing leaflet.
As we can see from the last snapshot of the simulation system, neutral dyclonine
molecules accumulate. In figure 2.16, we show the total (dashed line) number of charged
(black) and neutral (red) dyclonine outside of the bilayer and the number of dyclonines
that move as cluster (solid line). We see that neutral dyclonines come together before
10 ns and all float together till one of them enters into the bilayer around 40th ns. After
this time, the remaining seven molecules move as a cluster. Even though two of them
16
Figure 2.12: Eight neutral dyclonine outside of the bilayer was simulated for 250ns. Only
one of them was successful in insertion process, remaining ones seem to be accumulated
in water.
leave the aggregate twice, they reassemble within a few nanoseconds. When we look to
behavior of charged dyclonine molecules we do not see a similar pattern. Although some
of the charged ones come together, the number of accumulated molecules barely reach
total number of molecules outside of the bilayer.
2.2.3 Neutral Dyclonine Inside the Bilayer
Since only one of the molecules in previous system was able to penetrate into lipid bilayer,
four neutral dyclonine molecules were inserted into lipid bilayer in order to analyze their
behavior inside of the model membrane.
In order to do that double lipid bilayer was constructed. For this purpose new bilayer
was built via charmm-gui with 128 DPPC, 2560 water molecules and 0.15 mM KCl which
corresponds to 4 K` and 4 Cl´ ions. The final system dimensions were 6.8 nm ˆ 6.8 nm
ˆ 5.8 nm. Construction of double bilayer was completed via duplication and assembly
of the newly generated membrane. Then, two dyclonine molecules were inserted into the
center of each bilayer (4D0 system). For this system, each conformation of dyclonine was
used once. System was simulated for 500 ns.
Initial and final configurations of the system are shown in Figure 2.17.
Position of each molecule with respect to time is shown in Figure 2.18. It is seen that
all four dyclonine molecules move freely in z direction. Three of the molecules change
the leaflet more than once during simulation, while the last one struggles with passing to
the other leaflet. While this can be caused by structural difference, it may be just artifact
of limited simulation time. Besides this bias of that dyclonine molecule (shown with red
line), distribution of their localization shows there is slight preference to locations |z| = 0,
1.1 nm.
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Figure 2.13: The one which is capable of enter into bilayer changes leaflet multiple times
(A) and does not have a preferred location in simulation box along bilayer normal (B).
Figure 2.14: Similar with charged ones, neutral dyclonine also inserts its tail first into bi-
layer. The color of interested dyclonine is shown opaque while other dyclonine molecules
are shown metallic.
Additionally, we aimed to understand whether molecules have specific orientations in
the bilayer. It is seen that all four molecules prefer to stay parallel to bilayer normal at
positions z = 2 nm and z = -2 nm as their head is close to head of phospholipids. Especially
three of the molecules show very similar pattern that they prefer to stay parallel to bilayer
normal around membrane borders and change their orientation while changing leaflet.
Figure 2.19 suggest molecules can change leaflet in two different paths. The aver-
age of four dyclonine molecules orientation distribution was averaged which is shown in
Figure 2.20. Here, molecule may first change its orientation within the leaflet and then
pass to the other leaflet (model I), or it may first change the leaflet and then arrange its
orientation (model II).
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Figure 2.15: Neutral molecules which are unable to enter into bilayer (bilayer borders are
shown with brown lines) can be in any orientation. The one which penetrates into bilayer
changes its orientation with respect to the leaflet located in. At upper leaflet it stays with
an angle of 0˝, while at lower leaflet it stays with an angle of 180˝.
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Figure 2.16: Accumulated (solid) and total (dashed) number of neutral (red) and charged
(black) dyclonine molecules in aqueous environment are shown. It is seen that neutral
dyclonine molecules form cluster within a few nanosecond and move as cluster for the
rest of the simulation then while charged molecules do not accumulate.
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Figure 2.17: Behavior of neutral dyclonine molecules inside of the bilayer was studied
by constructing double bilayer and introducing them to the center of the bilayer as initial
condition.
Figure 2.18: Neutral dyclonine molecules change leaflet multiple times during 500 ns
simulations.
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Figure 2.19: Distribution of angles of the defined vector (similar with 8D`) and 8D0
systems with respect to location along bilayer normal is shown. It is seen that while
changing leaflet, they change their direction of orientation in one of the leaflets rather
than changing it at the center of the bilayer. Membrane borders are shown with brown
lines.
Figure 2.20: Tilt angle and averages of orientation distribution of four dyclonine
molecules is shown (A). During translocation, drugs follow two paths. In model I, it
changes its orientation within the leaflet it already located and then passes to the other
leaflet. In model II, drug first crosses to the other leaflet and then changes its orientation
(B).
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2.3 Discussion
In order to understand the mechanism of drug permeation through lipid bilayer, MD sim-
ulations are widely used since it is possible to study drug - lipid interaction in atomistic
details. MD simulations have been used extensively to study wide range of molecules in-
cluding anticancer [22, 23], antiinflammatory [24, 25], antibacterial [26], anticonsulvant
[27], local anesthetics [15] drugs and many small compounds [28, 29, 30, 31, 32, 33, 34]
in lipid bilayer.
While it is possible to study only localization and orientation of drugs [26, 28, 35, 36]
in the membrane, there are many other studies which also focus on their energy profile
and permeability [27, 25, 33, 34]. These molecules include ionizable basic molecules like
p-tyramine [33], arginine and lysine with their analogs [31], amitriptyline and clozap-
inetryptophan [37], tryptophan [34] in both charged and neutral states of the compounds.
Local anesthetic drugs like benzocaine [13] and articaine [38] were also studied but only
in their neutral states. Therefore, studying dyclonine with both states provides further
insight about local anesthetic drug - lipid interaction and permeation.
MD simulations performed with dyclonine provides detailed information about be-
havior of both states of the drug interacting with lipid bilayer. It is seen that dyclonine
molecules are able to enter into bilayer in both states. However we see that while neutral
dyclonine is capable of changing leaflet, charged ones are stuck to the head groups of the
phospholipids. Additionally, we do not see any dissociation events for both states within
simulation times.
Position distribution of charged dyclonines clearly shows that they prefer to local-
ize slightly below of the phosphorous atoms (Figure 2.7B). As dyclonines are positively
charged and phosphate groups of lipids are negatively charged, it is expected to see this
localization. Because of this electrostatic interactions charged dyclonines are unable to
pass to other leaflet. On the other hand, neutral dyclonines inside of the bilayer are free
to move along the bilayer normal within the membrane borders (Figure 2.13B, Figure
2.18B).
When we focus on how they insert into bilayer we see that both charged and neutral
dyclonine molecules first insert their tail (Figure 2.8, Figure 2.14). Otherwise, if the
molecule approaches to the bilayer with their head group, it is not possible for dyclonine
to complete insertion process (Figure 2.9).
In the simulation system in which we initiated neutral dyclonines in aqueous environ-
ment, only one of them was able to enter into the bilayer. Normally, we expect that neu-
tral dyclonine molecules should enter into lipid bilayer because dyclonine is a lipophilic
molecule with logP 3.68. However we see that they aggregate in water in a very short time
scale which prevents their penetration into lipid bilayer (Figure 2.16). This illustrates the
importance of the solubility of the drugs. While we see this aggregation in neutral state,
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we do not encounter such situation for charged molecules. As charged molecules are
more soluble in water compared to neutral ones, they can move individually in the water
which facilitates their permeation into bilayer.
As we analyze their orientation inside of the bilayer, we see that all charged molecules
prefer to stay parallel to bilayer normal (Figure 2.11). Actually, with this orientation
dyclonine molecules mimics phospholipids. Similar to phospholipids charged dyclonine
has a hydrophilic and hydrophobic parts and they orient their hydrophobic part through
bilayer core while keeping hydrophilic part around lipid heads.
For neutral dyclonine, it seems that when the molecule changes the lipid leaflet either
it first changes its orientation direction (from being parallel in `z direction to ´z direc-
tion, or vice versa) then passes to other leaflet, or it first passes to other leaflet and then
changes its orientation direction (Figure 2.20). For the fourth molecule it is seem that it
cannot pass to lower leaflet completely, it moves between z = 2 nm and z = ´0.5 nm. At
these edges it prefers to stay in parallel conformation to bilayer normal and can be in any
orientation between these borders.
Overall, we can say that both charged states of dyclonine have different characteristics
when they interact with the lipid bilayer. It is seen that neither of the states are capable
of completing permeation process. While charged dyclonine can enter into bilayer it is
unable to change its leaflet. On the other hand, neutral dyclonine can both penetrate into
bilayer (even though we only have one event caused by accumulation in water) and passes
to other leaflet.
Note that we do not see any dissociation events for both states. The reason why both
charge states of the molecule can perform only specific parts of the permeation process
is caused by heterogeneous structure of the lipid bilayer. Therefore analyzing the per-
meation of molecules in discrete states (insertion, translocation and dissociation) with
three-layer perspective should provide deeper insight about overall process.
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Chapter 3
Permeability from MD simulations
3.1 Theory and Methods
3.1.1 Diffusion Equation and Permeability
Drugs permeate through lipid bilayer into the cell (or liposome) as long as outside con-
centration is greater than the inside concentration. This concentration difference induces
molecules to flow through the lipid bilayer. Therefore, flux density of drugs is propor-
tional to the concentration difference which is described as,
j “ P∆c, (3.1)
where ∆c “ cout´ cin. Here, this proportionality constant is the permeability coefficient.
Permeability coefficient of a molecule is an indicator of how fast that molecule can
pass through the membrane. In other words, it is the ”conductivity” of the membrane for
this specific molecule.
As the molecule diffuses along the bilayer normal, the change of concentration follows
the Smoluchowski equation,
Bc
Bt “ ´
Bj
Bz “ ´
B
Bz
„
´Dpzq BcBz `Dpzqfpzqc

, (3.2)
where cpz, tq is the drug concentration, jpz, tq is the current density, Dpzq is the diffusion
coefficient, and fpzq “ ´u1pzq is the force where upzq ” Gpzq{RT (Gpzq is the free
energy along z, R is the gas constant, and T is the absolute temperature.)
Smoluchowski equation, (3.2), leads to determine permeability coefficient of molecules
via the relation (3.3) which was originally proposed by Marrink and Berendsen [39]
1
P “
ż L
´L
dx
e∆upxq
Dpxq (3.3)
where ∆upxq is the energy difference of the molecule being at position x and being in
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aqueous environment (∆upxq “ upxq ´ uout) and Dpxq is diffusion coefficient at cor-
responding position. Lets assume ´L corresponds to a point outside of the cell and L
corresponds a point inside of the cell since the drug is applied from outside of the cell.
Note that due to the symmetry of the membrane ∆upxq “ ∆up´xq and Dpxq “ Dp´xq
where center of membrane is fixed to x “ 0 nm.
It is seen that in order to estimate permeability coefficient of dyclonine, we need to
have free energy and diffusion profiles along lipid bilayer.
3.1.2 Free Energy Profiles from Umbrella Sampling Simulations
In order to be able to determine complete profile of free energy of charged and neutral
dyclonine, umbrella sampling (US) [40] methodology was used. With this method, sys-
tem of interest is simulated individually with introducing artificial potentials to specific
”windows” along reaction coordinate. For our system, as we want to obtain the energy
profile between two states which are the situations that the molecule is in the aqueous en-
vironment (z “ 4 nm) and at the center of the bilayer (z “ 0 nm), the reaction coordinate
of our system is simply z “ 4 nm - z “ 0 nm. For US simulations, separate umbrellas
were generated with certain distances between two windows.
Construction of the complete profile was performed by combining the information
from all these individual simulations. Weighted Histogram Analysis Method (WHAM)
can be used to combine all these information from different simulations with biased po-
tential [41]. This method aims to merge the data from all simulations on the basis of max-
imum overlapping method [42]. While the method developed by Bennet which combines
the information of neighboring windows that have the highest overlap, WHAM provides
combination of all umbrellas resulting unbiased profile with minimum statistical error.
For umbrella sampling simulations, center of mass of the head groups of dyclonine
molecules were restrained to specific locations (windows) along the lipid bilayer normal.
For a specific restraining position, same simulation box was used for the two states of the
molecule. For example, for the umbrella of z “ 4 nm charged dyclonine was restrained
to z “ `4 nm while neutral dyclonine was restrained to z “ ´4 nm. As example, initial
views are shown in Figure 3.1 for umbrellas |z| = 4 nm, |z| = 2.1 and |z| “ 1.1 nm. Since
our simulation box is greater than 9 nm, two molecules did not interact with each other
even at z “ 4 nm through periodic boundaries.
On the other hand, to eliminate the interaction while restraining positions get closer to
each other inside of the membrane, separate simulation boxes were used for the umbrellas
smaller than z “ 1.1 nm. In Figure 3.2 the initial view of the system where |z| “ 0.6 nm
is shown.
Selected positions along lipid bilayer, corresponding force constants and simulation
durations are given in Table 3.1. For the positions 3 nm ď |z| ď 4 nm along reaction
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Figure 3.1: Both charged (up) and neutral dyclonine (down) molecules were inserted into
the same system which provided time efficiency. Initial views of the simulation boxes are
shown for |z| = 4, 2.1 and 1.1 nm windows.
Figure 3.2: Simulations systems of charged (left) and neutral (right) were separated for
the umbrellas |z| ď 1 nm in order to eliminate the interaction of two dyclonine molecules.
coordinate umbrellas were placed with 0.5 nm distances. In order to obtain overlapped
position distributions of two neighbor umbrellas, spring constants for these umbrellas
were selected relatively small (f “ 0.5 kcal mol´1A˚´2, f “ 0.15 kcal mol´1A˚´2 and
f “ 0.5 kcal mol´1A˚´2 for |z| “ 4 nm, |z| “ 3.5 nm and |z| “ 3 nm, respectively).
The interval between two neighboring umbrellas were decreased up to 0.1 nm as the
drugs approached to lipid bilayer. Therefore spring constants were increased and kept at
2 kcal mol´1A˚´2 for the umbrellas |z| ă 2.6 nm. As it was mentioned before, separate
simulation boxes were used for the positions |z| ă 1.1 nm. For neutral dyclonine interval
of the umbrellas was increased to 0.2 nm and spring constants were decreased to 1 kcal
mol´1A˚´2 and 0.8 kcal mol´1A˚´2.
In order to obtain unbiased profile, position distributions of each window should over-
lap with at least its closest neighbors. To check it, position distributions of both charged
(Figure 3.3, left) and neutral (Figure 3.3, right) molecules were plotted. It is seen that
each umbrella overlaps at least with its closest neighbors’ distributions.
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z/nm k/kcal mol´1A˚´2 T /ns
D` D0 D` D0
4.0 0.5 20
3.5 0.15 20
3.0 0.5 15
2.8 0.8 15
2.6 1.0 15
2.5-2.1 2.0 15
2.0 2.0 20
1.9-1.4 2.0 15
1.3 2.0 20
1.2-1.1 2.0 15
1.0 2.0 1.0 15
0.9 2.0 - 15 -
0.8 2.0 0.8 15 20
0.7 2.0 - 15 -
0.6 2.0 0.8 15 20
0.5 2.0 - 15 -
0.4 2.0 0.8 15 20
0.3 2.0 - 15 -
0.2 2.0 0.8 15 20
0.1 2.0 - 15 -
0 2.0 0.8 15
Table 3.1: Harmonic force constants (k) and total simulation time (T ) for corresponding
restraining positions (z) of the umbrella potentials.
3.1.3 Local Estimate of Diffusion
Diffusion coefficients can be determined locally from position time correlation functions
(pTCF). Hummer [43] states that
DpZq “ rVarpzZqs
2ş8
0
dtxδzZpτ ` tqδzZpτqyτ , (3.4)
where zZ is the position of the molecule restrained at location Z, z¯Z “ xzZptqyt is the
average of the position for that specific umbrella at Z and δzZptq “ zZptq ´ z¯Z denotes
the deviation of zZ from its average.
Note that the denominator in (3.4) is the area under the pTCF,
CZptq “ xδzZpτ ` tqδzZpτqyτ , (3.5)
In order to estimate (3.5), we fit each umbrella’s pTCF to exponentially decaying func-
tions. While correlation functions perfectly fit to monoexponential function in aqueous
environment, it is hard to postulate it for the umbrellas smaller than |z| =3.0nm. Therefore
curves below of that point are needed to fit to di- and even tri- exponential functions.
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Figure 3.3: Position distributions of both charged (left) and neutral (right) dyclonine
molecules are successful in overlapping with their neighbors’ distributions.
CZptq “
mÿ
n“1
aZne
´t{τZn , (3.6)
where m equals to 1, 2 or 3 for mono-, bi- or tri- exponential functions, respectively.
All umbrellas along reaction coordinate were fit to mono-, bi- and tri- exponential
functions to see the difference better. As it is seen in Fig. 3.4, there is no notable difference
in mono-, bi- and tri- exponential fits for both D` and D0 at z “ 4.0 nm where the
molecules locate in water. On the other hand, as it is seen in Fig. 3.5 while mono- and bi-
exponential functions are unsuccessful to fit to data at the center of the membrane (z “ 0
nm), tri- exponential function fits better to pTCF of D0 (right) and almost perfectly to
pTCF of D` (left). Note that in order to correct the difference in scale of pTCF caused
by usage of different spring constants for umbrellas, both x and y axes are multiplied with
f{RT of that umbrella where f is spring constant, R is gas constant and T is temperature
(see Table 3.1 for force constants).
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Figure 3.4: pTCFs (solid) in aqueous environment (z “ 4 nm) are fit to mono- (dashed),
bi- (dotted) and tri- (dotted dash) exponential functions for charged (black, left) and neu-
tral (red, right) dyclonine molecules. Both axes are rescaled with corresponding force
constants, f/RT.
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Figure 3.5: pTCFs (solid) at the center of bilayer (z “ 0 nm) are fit to mono- (dashed),
bi- (dotted) and tri- (dotted dash) exponential functions for charged (black, left) and neu-
tral (red, right) dyclonine molecules. Both axes are rescaled with corresponding force
constants, f/RT.
Fitting the pTCFs to bi- and tri- exponential functions reveals that there are motions
with different time scales. The need to fit the pTCFs to more than one exponential does not
occur when the molecule was in the aqueous environment as mentioned before. Since it
arises when the molecule starts to approach to the bilayer the reason can be the interaction
of molecule with lipids.
While fitting pTCF, it was noticed that for some umbrellas τZ coefficient of slowest
component was unrealistically high since correlation functions do not converge to zero.
Therefore these coefficients were restricted with boundaries.
In order to determine the “goodness” of the fits of all three exponentials quantitatively,
difference between pTCF and fit functions was defined as error. Error was calculated as,
Epzq “
ż tf
ti
|CCpt˜q ´ CF pt˜q|dt˜, (3.7)
where CCpt˜q is the calculated value and CF pt˜q is the fit value for corresponding time point
in the correlation functions. ti “ 0 ns and tf “ 1.4 ns ˆf{kBT . Estimation of the error
was done for the logarithmic scale of the time axis in order to increase the participation
of the points in the fast decaying part of the correlation function.
Calculated errors for bothD` andD0 are shown in Fig. 3.6. It is seen that while errors
of monoexponential functions are fairly low in aqueous environment, for the umbrellas
z ď 2.8 nm errors are pretty high for dyclonine. Additionally, it is seen that both bi-
and tri- exponential functions fit better than monoexponential functions throughout the
reaction coordinate. Also, triexponential functions are better than biexponential functions.
Diffusion coefficients for all mono-, bi- and tri- exponential functions are calculated
for both charged (black) and neutral (red) states (Fig. 3.7). It is seen that diffusion coef-
ficients calculated from monoexponential fits are apparently different from the ones cal-
culated from bi- and tri- exponentials. On the other hand, diffusion coefficients estimated
from bi- and tri- exponential fits are not much different from each other yet they are same
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Figure 3.6: Errors of mono- (dashed), bi- (dotted) and tri- (dotted dashed) exponential
functions for charged (black, left) and neutral (red, right) dyclonine are shown.
for most of the points even though the success of fits (errors) are different. Therefore, for
the umbrellas in the water (z = 3, 3.5 and 4 nm) diffusion coefficients of monoexponential
functions, for the rest of the umbrellas diffusion coefficients of biexponentials are used
for local estimate of diffusion.
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Figure 3.7: Diffusion coefficients calculated from mono- (dashed), bi- (dotted) and tri-
(dotted dashed) exponential functions for charged (black, left) and neutral (red, right)
dyclonine are shown.
3.1.4 Global Estimate of Diffusion Profile
Various mean first passage times for 1D diffusion in a potential are available. For a ă
z ă x with a reflecting boundary at a and an absorbing boundary at x the MFPT is[44]
τ |axąÑx pzq “
ż x
z
dζ
eupζq
Dpζq
ż ζ
a
dη e´upηq. (3.8)
Note that, because this expression contains the product of eupζq and e´upηq, the arbitrary
zero reference of the free energy upzq is immaterial, as long as the same reference point
is used consistently. Similarly, for x ă z ă b with an absorbing boundary at x and a
30
reflecting boundary at b the MFPT is[44]
τăxb|xÐ pzq “
ż z
x
dζ
eupζq
Dpζq
ż b
ζ
dη e´upηq. (3.9)
Netz and coworkers have introduced the round-trip (τrt) time, which is the MFPT to
go from z to x plus the MFPT to go from x to z. For a ă x ă z ă b, with reflecting
boundaries at a and b the τrt is
τ |ab|xè pzq “ τăxb|xÐ pzq ` τ |aząÑz pxq “ Zab
ż z
x
dζ
eupζq
Dpζq , (3.10)
where
Zab “
ż b
a
dη e´upηq. (3.11)
For the diffusion profile this leads to
Dxèpzq “ Zabe
upzq
dτ |ab|xè pzq{dz
. (3.12)
Similarly, when z is between a and x (a ă z ă x ă b), the τrt is
τ |ab|éx pzq “ τ |axąÑx pzq ` τăzb|zÐ pxq “ Zab
ż x
z
dζ
eupζq
Dpζq , (3.13)
and the resulting diffusion profile is
Déxpzq “ ´ Zabe
upzq
dτ |ab|éx pzq{dz
. (3.14)
In our analysis, we use the drug trajectories in the free (unrestrained) MD simulations
to obtain estimates of the τrt, τ
|ab|
xè pzq and τ |ab|éx pzq for several values of z P pa, bq. When
estimating τ |ab|xè pzq we choose x “ a, whereas for τ |ab|éx pzq we choose x “ b. We denote
the diffusion profiles obtained from these τrt by DaÐ and DÑb, respectively.
Since both D` and D0 do not show a complete process of permeation in free simu-
lations, we determined to introduce virtual boundaries along bilayer which provide esti-
mation of the diffusion profiles as fragments. Reaction coordinate was divided into four
regions given in Table 3.2 and Figure 3.8.
Round trip time (RTT) values along bilayer normal were determined with 0.05 nm
resolution. As explained above, RTT is the summation of two mean first passage times
(MFPTs) which are (i) time for a molecule starting from an initial point within the interval
(restricted with one absorbing and one reflecting boundaries) till arriving to its absorbing
boundary and (ii) time for that molecule restarting from the absorbing boundary till reach-
ing back the initial point. In order to estimate RTTs, averages of Tăxb|xÐ pzq and T |aząÑz pxq (or
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regions range
I ´1.4 nm - 1.4 nm
II |1.4| nm - |2.6| nm
III |2.6| nm - |3.0| nm
IV |3.0| nm - |4.0| nm
Table 3.2: Fragments of reaction coordinate separated by virtual boundaries for estima-
tion of τrt.
Figure 3.8: Reaction coordinate was divided into four regions with virtual boundaries.
T
|axąÑx pzq and Tăzb|zÐ pxq) are summed. Observed events were divided into three groups, and
each of them had approximately equal number of events. Standard deviation of T |ab|xè pzq
(or T |ab|éx pzq) was determined by the relation σrt “
a
σxÐpzq2 ` σÑzpxq2.
For diffusion profile of dyclonine in region I, 480 ns 4D0 and 250 ns 8D0 simulations
were used. For determination of T |ab|xè pzq, first τăxb|xÐ pzq and T |aząÑz pxq should be calculated.
In Figure 3.9 left panel, time is given for a molecule starting from an initial point within
the interval and reaching absorbing boundary and at right panel time is given for the
molecule restarting from absorbing boundary and reaching back the initial point. In both
graphs we see monotonically increasing plots as expected since time increases as the
distance between absorbing boundary and initial point expands.
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Figure 3.9: Tăxb|xÐ pzq and T |aząÑz pxq values which are calculated from 8D0 simulations for
region I
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In the TÑzpxq plot, there is a jump between z “ 1.3 nm and z “ 1.4 nm. The reason
is there are some events in which the molecules can reach to z “ 1.3 nm and turns back
without touching z “ 1.4 nm (and touches to z “ 1.4 nm later, data not shown) which
automatically increases the duration. Since our sampling is limited, these kind of artifacts
are inevitable.
Summation of TxÐpzq and TÑzpxq for each point gives the round-trip time (Figure
3.10, left panel). Even though overall graph shows a monotonically increasing pattern,
we see there are points that is lower than the previous ones which leads a negative slope
resulting negative diffusion coefficient. In order to avoid this unrealistic diffusion profile,
T
|ab|
xè pzq is smoothed with using five (blue) and seven (black) points. Calculated diffusion
values are shown in Figure 3.10 right panel. Although smoothing works for most of the
points, it is inevitable to see jumps where the slope of T |ab|xè pzq is small. This problem is
partially overcome by increasing the number points used for smoothing. We see that even
though smoothing with different numbers of points do not affect the T |ab|xè pzq profile, it
leads more apparent difference in diffusion profile. Furthermore, there is an increase at
absorbing boundary which is not unique to this interval.
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Figure 3.10: T |ab|xè pzq profile was determined from free simulations (left). Red stars show
MD data, blue and black lines show smoothed values with five and seven points, respec-
tively. Diffusion profiles were determined from smoothed T |ab|xè pzq values (right).
T
|axąÑx pzq and Tăzb|zÐ pxq values for the same interval shown in Figure 3.11. Again in the
left panel, time is shown for each initial point within the interval till reaching to absorbing
boundary (z “ 1.4 nm) (T |axąÑx pzq). In the right panel duration is shown starting from
the absorbing boundary to arriving initial point (Tăzb|zÐ pxq). Both plots are decreasing
monotonically as expected since the starting point getting closer to absorbing boundary
except the first two points of figure on the right. The reason is there are two events in
which crossing starts from absorbing boundary and reaches to z “ 1.3 nm in a long
duration which never touches to z “ 1.4 nm so this long duration is counted for z “ 1.3
nm but not z “ 1.4 nm (data not shown).
T
|ab|éx pzq is shown in Figure 3.12, left panel. Data was smoothed for five and seven
points again. Diffusion profiles were obtained for these two curves of RTTs (Figure 3.12,
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Figure 3.11: T |axąÑx pzq and Tăzb|zÐ pxq values which are calculated from 8D0 simulations for
region I
right panel). We see that diffusion profiles give unrealistic diffusion values at reflecting
boundary because of positive slope which results negative diffusion values. Moreover,
there is an increase at absorbing boundary.
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Figure 3.12: T |ab|éx pzq determined from free simulations (left). Red stars show data, blue
and black lines show smoothed data with five and seven points, respectively. Diffusion
profiles determined with smoothed RTT values (right).
Profiles of T |ab|xè pzq and T |ab|éx pzq directions for z “ ´1.4 nm and z “ 1.4 nm interval
is shown in Figure 3.13. Same analysis performed for the interval of z “ ´1.0 nm and
z “ 1.0 nm to see whether we can obtain similar profiles, in other words, whether choice
of virtual borders effect the resulting profile or not. It is seen that obtained profiles are con-
sistent with each other suggesting boundary selection does not effect the diffusion profile.
Additionally, we still see increased diffusion values closer to absorbing boundary. Actu-
ally, these jumps at absorbing boundary is also shown in other studies which use MFPT
to determine diffusion coefficients [45]. The reason is explained as the non-Markovian
motion of the molecule at smaller time scales which arises at absorbing boundary.
Using similar strategies diffusion coefficients of z “ 1.4 nm and z “ 2.6 nm interval
were determined. For determination of τrt for this interval 8D` free simulations were
used. RTT data points are again smoothed with five and seven points. It is seen that
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Figure 3.13: Diffusion profiles are shown for z “ ´1.4 nm - z “ 1.4 nm (black) and
z “ ´1.0 nm - z “ 1.0 nm (red) intervals.
for both T |ab|xè pzq (Figure 3.14) and T |ab|éx pzq) (Figure 3.15), there is not much difference
between two smoothing strategies in both RTT and diffusion profiles. Not surprisingly,
in both directions there is an increasing profile at absorbing boundary as z “ ´1.4 nm -
z “ 1.4 nm interval.
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Figure 3.14: Tăxb|xÐ pzq, τ |aząÑz pxq, τ |ab|xè pzq and diffusion profiles for region II.
We cannot determine diffusion profile for region III since we do not have enough
sampling to determine RTT in this interval. For the estimation of RTT we need to have
events in which molecules move through both directions along bilayer normal. However
as we do not see any dissociation event in our 8D` simulation system, there is no molecule
moving in both directions within this interval.
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Figure 3.15: T |axąÑx pzq, τăzb|zÐ pxq, T |ab|éx pzq and diffusion profiles for region II.
Lastly, region IV was analyzed for both T |ab|xè pzq (Figure 3.16) and T |ab|éx pzq (Figure
3.17) to determine diffusion profile in aqueous environment.
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Figure 3.16: Tăxb|xÐ pzq, T |aząÑz pxq, T |ab|xè pzq and diffusion profiles for region IV.
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Figure 3.17: T |axąÑx pzq, Tăzb|zÐ pxq, T |ab|éx pzq and diffusion profiles for region IV.
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3.1.5 Permeation in Three Layers
As it was done for water previously [46], it is informative to study permeation of the
molecule in step wise manner. This approach provides the insight of how different layers
(hydrophobic and hydrophilic) of membrane structure affect insertion, translocation and
dissociation processes of dyclonine. We set z “ ´a nm and z “ a nm as interface of hy-
drophobic and hydrophilic regions for extracellular and intracellular leaflets, respectively.
As complete permeation process is the continuous steps of insertion, translocation and
dissociation, we can split (3.3) as
R “
ż ´a
´L
dx
e∆upxq
Dpxq `
ż a
´a
dx
e∆upxq
Dpxq `
ż L
a
dx
e∆upxq
Dpxq . (3.15)
Note that regions between z “ ´L - z “ ´a and z “ a - z “ L correspond to
hydrophilic layers of membrane including lipid head groups and area between z “ ´a -
z “ a corresponds to hydrophobic layer including lipid tails. Additionally, it is important
to indicate that first and third terms in right hand side are equal to each other since upzq “
up´zq and Dpzq “ Dp´zq due to symmetric construction of the bilayer.
The first term in the right hand side represents the resistance of insertion process
Ri ”
ż ´a
´L
dx
e∆upxq
Dpxq ”
1
Pi (3.16)
where Pi is permeation coefficient of insertion. While the second term corresponds to
resistance of translocation process, we need to make a correction here. As ∆upxq “
upxq ´ uout and we want to estimate permeation of translocation process it is needed to
determine the upzq´ up´aq where z “ ´a is the position where translocation starts. The
second term at the right hand side of (3.15) is
Rt ”
ż a
´a
dx
e∆upxq
Dpxq . (3.17)
And when we introduce e´up´aqeup´aq, equation (3.17) yields
Rt ”
ż a
´a
dx
eupxq´uout`up´aq´up´aq
Dpxq , (3.18)
which can be substituted as
Rt ” e´uouteup´aq
ż a
´a
dx
eupxq´up´aq
Dpxq ”
1
PPt . (3.19)
Note that e´uouteup´aq is the ratio of number of molecules in water to number of
molecules in lipid so we define partition coefficient P as e´up´aq{e´uout . Also, in that
relation Pt is the permeability coefficient of translocation process.
Similarly for the dissociation process, we can write
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Rd ”
ż L
a
dx
e∆upxq
Dpxq “ e
´uouteua
ż L
a
dx
eupxq´upaq
Dpxq ”
1
PPd , (3.20)
where Pd is the permeability coefficient of dissociation process.
As it was indicated before first and third term are equal to each other in relation (3.15),
Pi “ PPd, (3.21)
and total resistance is
R “ Ri `Rt `Rd, (3.22)
which yields
1
P “
1
Pi `
1
PPt `
1
PPd . (3.23)
3.2 Results
3.2.1 Free Energy Profiles
Unrestrained Simulations
The probability distributions of the charged (Figure 2.7B) and neutral (Figures 2.13B
and 2.18B) dyclonine molecules along the bilayer normal are proportional to Boltzmann
factor of the free energy:
ppzq9e´GpzqkBT . (3.24)
Here ppzq is the probability of being at location z, Gpzq is the free energy per mole at
location z.
The free energy profiles of the systems 8D`, 8D0 and 4D0 deduced from equation
(3.24) are shown in Figure 3.18. Note that energy profiles can be shifted in y axis since
normalization is missing in equation (3.24). We see that charged molecules (black) en-
counter a slight barrier at around z “ 2.5 nm and reach their minimum energy value at
around z “ 1.9 nm at just below of phosphorous atoms of phospholipids.
When we analyze the energy profiles of neutral systems, we see there is a high energy
barrier at z “ 2 nm for 8D0 system (dashed red). As neutral dyclonine molecules move
as a cluster in water, this energy barrier is not for an individual dyclonine molecule, it is
the energy barrier for accumulated dyclonine molecules. Because when they accumulate
once, they almost never dissociate (Figure 2.16) and act as one bulky molecule. On the
other hand, both neutral dyclonine systems (4D0 solid red, 8D0 dashed red) provide a
consistent profile inside of the bilayer that they have minimum at around z “ 1.1 nm and
do not fluctuate much at positions deeper than that location.
39
 z (nm)
0 1 2 3 4
 
G
(z)
 (k
ca
l/m
ol)
-6
-4
-2
0
2
4 8D +
8D 0
4D 0
Figure 3.18: Free energy profiles obtained from position distributions of 8D` (black solid
line), 8D0 (red dashed line) and 4D0 (red solid line) systems are shown.
Although we are able to obtain energy profiles for charged and neutral dyclonine
molecules, we can only have them partially. As we do not have energy values for charged
one where |z| <1 nm and |z| >2 nm for neutral ones, we are unable to determine perme-
ation with these profiles.
Restrained Simulations
Free energy profiles obtained by umbrella sampling simulations are shown in Figure 3.19
overlapped with profiles obtained from 8D`, 8D0 and 4D0 simulations. For neutral dy-
clonine (red), for the locations |z| <2 nm we see that energy values obtained by umbrella
sampling (dotted solid line) is consistent with the profiles obtained by 8D0 (dashed line)
and 4D0 (solid line) systems. Similar with 8D0 and 4D0 energy profiles, neutral molecule
prefers to stay around z “ 1.1 nm. On the contrary of the profile obtained by 8D0 system
simulations, we see no barrier while neutral dyclonine is penetrating into bilayer. This
is expected because as it was mentioned before, the energy barrier seen for 8D0 system
does not represent an individual molecule, but for a bulk composed of seven neutral dy-
clonines. We see that for neutral molecule locating around z “ 1.1 nm is approximately
8 kcal/mol more favorable compared to outside of the bilayer. Since neutral dyclonine is
a hydrophobic molecule this energy profile is an expected outcome.
Note that neutral dyclonine is initiated from 2.8 kcal/mol above of charged one in
aqueous environment. The reason is the fact that charged dyclonine is found 10pKa´pH
times more abundant than neutral one. Boltzmann distribution yields
pD`
pD0
“ e
´Ga`qpzq
kBT
e
´G0aqpzq
kBT
(3.25)
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Figure 3.19: Free energy profiles obtained from umbrella sampling simulations for
charged (dotted black) and neutral (dotted red) are shown overlapped with free energy
profiles obtained by unrestrained 8D` (black solid), 8D0 (red dashed) and 4D0 (red solid)
simulations.
where Ga`qpzq is free energy of charged dyclonine in aqueous environment, G0aqpzq is
free energy of neutral dyclonine in aqueous environment and pD`
pD0
is the ratio of charged
species to neutral ones which is equal to 10pKa´pH. Therefore,
kBT lnr10ppKa´pHqs “ ´GD`aq pzq `GD0aq pzq (3.26)
where pKa = 8.4, pH = 6.5 and T = 323 K. Since we chose the energy value of charged
dyclonine as zero in aqueous environment, energy of neutral dyclonine in aqueous envi-
ronment was set as 2.8 kcal/mol.
When we examine the energy profiles of charged dyclonine (black), we see that energy
profile obtained from umbrella sampling simulations are consistent for the 1.3 nm - 2.5
nm interval. It is hard to claim that it is also consistent for the interval of 1 nm - 1.3
nm, the reason may be the insufficient sampling of unrestrained simulations as charged
dyclonine is not able penetrate into core of the membrane. In addition, we see a difference
for the locations |z|>2.5nm. The reason is simulation time of the unrestrained system. As
simulation duration increases, profile obtained from unrestrained simulations converges
to profile obtained from umbrella sampling simulations. In Figure 3.20, we see that when
only 100 ns of the simulation is used we see higher difference whereas we use 250 ns
simulations we see a closer profile.
As we force the charged molecule to locate in the core of the membrane, energy
barrier increases and reaches to approximately 7 kcal/mol at the center of the bilayer. The
reason is while dyclonine is drafted into the core, water molecules and lipid head groups
are also dragged with the charged head group of dyclonine. In Figure 3.21, we see that
more than four phosphorous atoms are located in the core region (which is defined as the
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Figure 3.20: Increasing the simulation time from 100 ns (dotted dashed line) to 250 ns
(solid line) provides more consistent profile with umbrella sampling simulations (dotted
solid line).
area between z “ ´1.3 nm and z “ 1.3 nm) of the membrane as the charged molecule
is forced to locate inside of the membrane. On the other hand, number of phosphorous
atoms do not increase with drift of neutral dyclonine through the inside of the membrane
since it does not pull phosphorous atoms. Similar with phosphorous atoms, number of
0 0.5 1 1.5 2 2.5 30
1
2
3
4
5
6
 z (nm)
 
# 
of
 p
ho
sp
ho
ru
s 
at
om
s
 
 
D+
D0
0 0.5 1 1.5 2 2.5 30
10
20
30
40
50
60
 z (nm) 
 
# 
of
 w
at
er
 m
ol
ec
ul
es
 
 
D+
D0
Figure 3.21: Number of phosphorous atoms can increase up to four when charged dyclo-
nine is located in the core region (black) while no phosphorous atom is drifted into core
region when neutral dyclonine is dragged into lipid core (red) (left). Number of water
molecules increases up to 55 when charged dyclonine is located in the core region (black)
while number of water molecules does not change no phosphorous atom is drifted into
core region when neutral dyclonine is dragged into lipid core (red) (right).
water molecules increases as charged dyclonine approaches to the center of the bilayer.
In Figure 3.21 at left, it is seen that number of water molecules in the lipid core reaches
to 55 when charged dyclonine is forced to locate at the center (black), while the number
of waters is similar when neutral dyclonine is located in aqueous environment and at the
center of the membrane (red).
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Views of the lipid bilayers for the umbrellas in which molecules are located at the
center of the bilayer is shown in Figure 3.22. Phosphorous atoms (greenish brown) and
water atoms (red) penetrate into bilayer when charged dyclonine is located at the center
(left), while they do not invade when neutral dyclonine is located at the center (right).
Figure 3.22: While charged dyclonine molecule cause deformation by dragging water
molecules and lipid head groups, neutral dyclonine does not change the structure of the
membrane.
3.2.2 Diffusion Profile
In this study, to calculate diffusion profile two approaches were used: global and local.
As global approach round-trip time of the molecules between two virtual boundaries are
estimated. As local approach pTCFs are used to determine diffusion coefficients.
Global estimate of diffusion profile
Diffusion profiles for all intervals are shown in Fig 3.23 (smoothing over seven points
are used). Solid lines show the profile of the condition which absorbing boundary is
greater than reflecting boundary and dashed lines show the profile of the condition which
reflecting boundary is greater than absorbing boundary. Black lines shows the diffusion
profiles determined from unrestrained simulations of charged dyclonine molecules and
red lines shows the diffusion profiles determined from unrestrained simulations of neutral
dyclonine molecules. It is seen that while diffusion is approximately 0.1 nm2/ns inside of
the membrane, it is order of magnitude larger (1.1 nm2/ns) in aqueous environment.
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Figure 3.23: Diffusion profiles are shown for all regions. Solid lines show the ones whose
absorbing boundary is greater than reflecting boundary, dashed lines show the ones whose
absorbing boundary is smaller than reflecting boundary.
Local estimate of diffusion profile
Resulting local diffusion values for charged (black circles) and neutral (red circles) dy-
clonine molecules are shown in Figure 3.24. We can see that charged and neutral states of
dyclonine have almost same diffusion values for the same positions. Moreover, it is seen
that diffusion coefficients determined via pTCF are consistent with the profile obtained
by round-trip time (Figure 3.24, black and red lines).
For simplicity, we fit the profiles to a hyperbolic tangent function (Figure 3.24, blue).
In order to confirm fitted profile (hyperbolic tangent function) is realistic, round-trip time
for the intervals are calculated and compared with the τrt determined from MD simula-
tions.
In Figure 3.25, τrt from MD simulations and τrt estimated from fitted diffusion pro-
files for region I (up), region II (middle) and region IV (down) are shown for τ |ab|xè pzq
(left) and τ |ab|éx pzq (right) . It is clear that with a few exception, calculated τrt from fitted
diffusion profile is in the range of MD τrt deviation which proves fitted diffusion profile
is successful in representing diffusion profile of the molecule in MD simulations.
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Figure 3.24: All diffusion profiles are shown determined via global approach (black and
red lines) and local approach (black and red circles). Overall profile is fitted to hyperbolic
tangent function (blue). Filled circles are the diffusion coefficients calculated from mono-
exponential fits, empty circles are the diffusion coefficients calculated from biexponential
functions.
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Figure 3.25: τrt calculated from fitted diffusion function consistent with τrt determined
MD simulations for region I (up), region II (middle) and region IV (down) are shown for
τ
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xè pzq (left) and τ |ab|éx pzq (right).
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3.2.3 Permeation
Choice of border (L) for the calculations of permeation is arbitrary and one could wonder
whether different choice of borders would effect the total permeability. In order to deter-
mine it we calculated overall permeations for L “ 3.5 nm, L “ 4 nm and L “ 4.5 nm.
Results are given in Table 3.3.
L “ 3.5 nm L “ 4 nm L “ 4.5 nm
D` 1.2406ˆ 10´3 1.2405ˆ 10´3 1.2405ˆ 10´3
D0 29.73 23.15 19.16
Table 3.3: Calculated permeability coefficients (cm/s) for charged and neutral dyclonine
with different choice of borders
It is seen that permeability coefficient of neutral molecule is approximately 104 times
higher than charged molecule independent of border selection. Therefore, L “ 4 nm will
be studied from now on.
Calculated resistance values for insertion, translocation and dissociation processes for
both states are given in Table 3.4.
1{Pi 1{Pt 1{Pd logP 1{P
D` 1.65 ns 35.86 ms 733.39 ns 2.6482 80.61 µs
D0 2.16 ns 20.96 ns 113.14 µs 4.7193 4.32 ns
Table 3.4: Calculated “resistances” (per nm) to the insertion into, translocation through,
and dissociation from a DPPC lipid bilayer. Together with logP, these give the total “re-
sistance” 1{P . (a “ 1.5 nm and L “ 4 nm.)
When we look the rates of insertion process, it is seen the resistance for both molecules
are approximately same which indicates charge state does not affect penetration of the
molecule into bilayer. On the other hand when we examine the translocation rates of both
states the effect of charge is seen clearly that translocation of neutral molecule is approx-
imately six order of magnitude faster than charged one. Lastly, in dissociation process
rate of charged dyclonine is approximately 150 times higher than neutral. Actually here
we see the effect of partition coefficient. Since neutral molecule prefers to stay at z “ a
104.7193{102.6482 times more than charged one, it encounters higher resistance during dis-
sociation.
Overall resistance of bilayer to charged molecule is approximately 20000 times higher
compared to neutral one which is the result of dominance of translocation process.
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3.3 Discussion
Free energies determined from unrestrained and restrained simulations provide consistent
profiles with exceptions of entrance the neutral and charged molecule. The difference of
neutral dyclonine is caused by the accumulation of molecules in water in unrestrained
simulations which act as a bulky molecule. And the difference of charged dyclonine is
caused by sampling size. As the duration of unrestrained simulations increase, free energy
profile converges to umbrella sampling profile.
In order to be able to permeate the bilayer, charged dyclonine needs to overcome a
high energy barrier („ 7 kcal/mol), while neutral molecule does not encounter any en-
ergy barrier. This situation is plausible since charged molecule deforms the membrane by
pulling phosphate groups and water molecules into the core of the bilayer which does not
occur for neutral molecule. Similar behaviors of ionizable basic species are reported. For
example, adamantanes (which are used for treatment of Parkinson’s Disease) encounter
a high energy barrier (ą 10 kcal/mol) in their protonated state while they do not face a
energy barrier in their neutral state [47]. In another study which focuses on amitripty-
line (which is an antidepressant), it is shown that molecule has an energy value of „ 4
kcal/mol in the center of the membrane while it is „ ´6 kcal/mol for neutral state [37].
Moreover there are other researches that study local anesthetic molecules. However, they
only analyze the molecules in their neutral state. For example, benzocaine can face a
slight energy barrier of „ 4 kcal/mol with respect to minimum energy value along the
bilayer normal which is around z “ 1.1 nm similar to dyclonine [13]. They also study
this molecule with two sets of atomic partial charge which cause a shift in local minima
of energy profile „ 2.5 kcal/mol while it does not change position of the minimum value
besides the difference of energy at the center compared to minimum value.
As we used in this research, it is possible to use both local and global approaches
to determine diffusion profile of the molecule since they provide consistent results. On
the other hand, both methodologies have some limitations. While using round-trip time
provides plausible and consistent results within the chosen virtual boundaries, complete
profile cannot be determined with this approach since we do not have any molecule that
leaves lipid bilayer within the simulation time. Meanwhile, using pTCF as local approach
provides a complete profile since we use umbrella sampling simulations to determine it.
However, some pTCFs are not successful in decaying to zero which changes the diffu-
sion coefficient in corresponding position (Converging to zero for pTCFs is important
because otherwise the area under the curve of the function increases resulting order of
magnitude smaller diffusion coefficient). In order to eliminate this issue, parameters of
fit are restricted which caused relatively less successful fits. Since we calculate diffusion
coefficients from these fits, dissonance of the pTCF and fit affects reliability of the cal-
culated coefficients. But for a specific position resulting coefficient with restrictions are
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more consistent with the coefficient calculated via round-trip time. Overall, it is possi-
ble to indicate that although both approaches have some limitations, consistent results for
complete profile is obtained with some corrections.
For diffusion profiles we can conclude that charged and neutral state have almost
same diffusion coefficient for a specific position and diffusion coefficient in aqueous en-
vironment is approximately one order of magnitude grater than the value inside of the
membrane. This outcomes are consistent with the studies for other molecules. For as-
pirin and ibuprofen (which are acidic drugs have antiinflammatory effect), it is reported
that diffusion inside of the membrane is „ 0.2 ˆ 10´5 cm2/s and it is order of magnitude
larger in water while the values are independent of charged state [25]. Additionally, in
another research that studies tyramine (which is a basic drug used as a neuroregulator)
has a diffusion coefficient around 0.7 ˆ 10´5 cm2/s in aqueous environment which is
approximately 5 times higher than the coefficients inside of the bilayer [33].
Studying permeation of the molecule with three-layer view provides detailed informa-
tion of characteristic behaviors of insertion, translocation and dissociation processes. It
is shown that while insertion process is completed within the same time scale, transloca-
tion of charged dyclonine lasts „ 106 times longer compared to neutral one. In addition,
dissociation of neutral molecule is completed „ 150 times slower than charged one. This
results show us, the ratio of charged dyclonine permeability coefficient to neutral dyclo-
nine (which is „ 104) is dominated by translocation process which is slightly recovered
by dissociation process while insertion process do not lead and contribution in terms of
the ratio.
It is important to remind that these resistance values are actually depended on the type
of phospholipids of the bilayer. It is plausible to think that the choice of chain length
and saturation state can affect the transition rate whereas type of head group may im-
pact insertion and dissociation rates. One would expect shorter chain would increase the
translocation rate resulting higher permeability coefficient. Mathai et al. studies water
permeation with different lipid types. For example, in that study permeability coefficients
of water through DMPC and DLPC bilayers (whose thicknesses are 2.54 nm and 2.09 nm,
respectively) are reported as 8.3 ˆ 10´3 cm/s and 10.4 ˆ 10´3 cm/s, respectively. As the
only difference between these two lipid types is the number of carbon atoms in lipid tail
(14 and 12, respectively) it is clear smaller chain length increases permeability coefficient
as rate of translocation increases. In a recent study, researchers wanted to see whether dif-
ferent head groups with the same chain length and saturation state affect the permeability
of a drug, norfloxacin (which is an antibacterial drug) or not[48]. For this purpose, they
compared the permeabilities of DOPC vs DOPE:DOPC (3:7) and DOPC vs DOPG:DOPC
(3:7) membranes. The only difference between phospholipid types (DOPC, DOPE and
DOPG) is their head group. DOPC has a cholin group and phosphate group (net charge
is zero), DOPE has amine group instead of cholin group resulting smaller head group
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(net charge is zero). On the other hand, DOPG is an anionic lipid. As a result of first
experimental condition, they see that permeability of the neutral norfloxacin decreases
with introducing of DOPC since it compacts the head groups of the lipids which obstructs
entrance of the drug into hydrophobic core. As second experimental condition, intro-
ducing anionic lipids DOPG also compacts phospholipids via forming hydrogen bonding
with neighboring phospholipids. It is indicated that, this situation blocks entrance of the
neutral molecule, again resulting a decrease in permeability coefficients. Therefore, it is
necessary to emphasize that selection of phospholipids are critical for permeation studies
which directly effects the calculated value.
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Chapter 4
Modeling Experimental Studies in Drug
Permeation
4.1 Introduction
In addition to computational studies, there are many experimental studies focus on deter-
mination of permeability coefficients of drugs and other molecules [48, 49, 50, 51, 52, 53].
One method to measure the permeability of proton is using markers as fluorescence which
are sensitive to change in pH [54]. Eyer et al. studied permeation of ionizable basic drugs
through liposomal membrane with fluorescence assay and emphasize that it is the first
method that uses fluorescence as pH indicator for measurement of drug permeabilites
[55].
For this purpose they develop a fluorescence array. Basically, they generate liposomes
composed of POPC and load fluorescence dye into these vesicles. This fluorescence dye
is pH sensitive and as pH changes in the range of 6 - 9, fluorescence signal increases
linearly. In that study they aim to measure permeability coefficient of basic drugs (that
are all aliphatic amine bearing drugs). In their system as a neutral drug enters into the
liposome and grabs a proton, pH of the environment rises. This leads to an increase in
fluorescence signal which would be a measure of drug permeation.
In the first 0.5 s of their measurement, they obtain a biexponentially increasing func-
tion and they fit to the relation,
F “ Ae´kat `Be´kbt ` F0, (4.1)
where F is the fluorescence signal, ka and kb are rates,A andB are corresponding weight-
ing functions and F0 is the coefficient to arrange the starting value.
Permeation rate of a molecule is determined via
ka “ PappAv
Vv
, (4.2)
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kD` “ PD`Av
Vv
, (4.3)
kD0 “ PD0Av
Vv
, (4.4)
kH` “ PH`Av
Vv
, (4.5)
where Papp is the permeability coefficient of the molecule, Av is area and Vv is volume of
the vesicle. Therefore, rate can be calculated as,
Papp “ ka r
3
, (4.6)
where r is the radius of the liposome.
One assumption to calculate Papp from charged and neutral species is,
Papp “ fD`PD` ` fD0PD0 , (4.7)
where fD` and fD0 are fractions, PD` and PD0 are permeability coefficients of charged
and neutral drugs, respectively. Note that for the conditions where PD` ! PD0 first term
in the right hand side of the equation (4.7) can be ignored. This leads to determination of
PD0 via
PD0 “ Pappp1` 10pKa´pHq, (4.8)
where fD0 “ 1{p1 ` 10pKa´pHq. Therefore in that research they indicate it is possible to
determine apparent permeability of the drug via fluorescence signal and this provides to
determine permeability coefficient of neutral state of the studied drugs.
For the same system, they also measure the fluorescence signal for 500 s. In long
scale, the signal of the fluorescence molecule decays. They fit the long scale profile to
four exponential function,
F “ Ae´kat `Be´kbt ` Ce´kct `De´kdt ` F0. (4.9)
Fitted coefficients of equation (4.1) to fluorescence signal of propranolol (whose pa-
rameters are used for modeling) is given in Table 4.1 ([55], Supplementary Table 1) .
Note that signs of A and B are negative, indicating ascending phases; C and D are
positive, indicating descending phases of the exponential function.
By using equation (4.6), Papp can be calculated as 1.95ˆ10´4 cm s´1 where ka “ 66.5
s´1 and r “ 87.5 nm. Permeability of neutral state can be estimated via equation (4.8)
0.77 cm s´1 where pH=5.9 and pKa=9.5. In the paper they report Papp “ 3.89ˆ 10´4 cm
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A ka (s´1) B kb (s´1) C kc (s´1) D kd (s´1)
´0.116 66.7 ´0.0326 17.5 0.0379 0.0418 0.0677 0.00319
Table 4.1: Coefficients of fitted four exponential function to fluorescence signal of pro-
pranolol.
s´1 and permeability coefficient of neutral species as 1.55 cm s´1.
4.2 Methods
For the modeling, experimental values of propranolol are used [55].
D`
koffÝÝáâÝ
kon
D0 ` H`, (4.10)
where D`, D0 are charged and neutral states of the drug and H` is proton. kon and koff
are association and dissociation rates, respectively.
Meanwhile note that
koff
kon
“ rD
0seqrH0seq
rD`seq “ Ka, (4.11)
where Ka is acid dissociation constant and remember pKa “ ´ logpKaq. Therefore,
koff {kon “ 10´pKa . (4.12)
In order to calculate pH change in the vesicle, rate equations of rD`i s, rD0i s and rH`i s
are written for charged, neutral drugs and proton, respectively.
Initial values for the modeling is given in Table 4.2.
Concentration Value Concentration Value
rHo` s 10´pH M rH`i st“0 10´pH M
rDo` s 10 µM rD`i st“0 0
rD0os rDo` sp10pH´pKaq µM rD0i st“0 0
rNao` s 0.2 M rNa`i st“0 0.2 M
rClo´ s 0.2 M rCl´i st“0 0.2 M
Permeability Coefficient Value Protonation Rate Value
PH` 10´7 cm s´1 kon 1010 M´1s´1
PD` 1.55 ˆ10´4 cm s´1 kFon 109 M´1s´1
PD0 1.55 cm s´1
PNa` 10´14 cm s´1
PCl´ 10´11 cm s´1
Table 4.2: Parameters used in the model.
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Outside concentration of species are assumed constant and koff values are determined
via equation (4.12). PD0 is taken as PD` ˆ 10´4 since 10´4 is the ratio of permeabil-
ity coefficient of charged dyclonine to neutral dyclonine that we determined in previous
chapter.
The change of rD`s, rH`s and rD0s in the vesicle can be written as
d
dt
rH`i s “ ´konrD0i srH`i s ` koff rD`i s ` kH`∆cH` , (4.13)
d
dt
rD0i s “ ´konrD0i srH`i s ` koff rD`i s ` kD0 ∆cD0 , (4.14)
and
d
dt
rD`i s “ konrD0i srH`i s ´ koff rD`i s ` kD`∆cD` . (4.15)
Note that first and second terms in the right hand side of equations (4.13), (4.14)
and (4.15) represent switch between two states of the molecule based on equation (4.10)
and the third term is the contribution of permeation. Here, ∆cH` , ∆cD` and ∆cD0 are
concentration difference between outside and inside (∆c “ cout ´ cin) of the vesicle for
proton, charged and neutral drug, respectively. kH` , kD` and kD0 are permeation rates of
the proton, charged and neutral drug, respectively.
Model 1a As first step, lets assume only neutral dyclonine can permeate the bilayer.
The permeability of charged molecule is ignored since, at least for our case, permeability
coefficient of charged drug is approximately 10´4 times smaller than the neutral one.
(Permeation of proton is not introduced since its permeability is even smaller than charged
drug [56]). So third terms in equations of (4.13) and (4.15) drop.
Model 1b Since there are also fluorescence molecules in liposomes which are also pro-
tonable (for HPTS pKa=8.5 [9]), it is expected to see an effect of the fluorophore on pH
profile in the vesicle.
F0
kFoffÝÝáâÝ
kFon
F´ ` H`, (4.16)
where kFon and k
F
off are association and dissociation rates of fluorophore.
Therefore change of fluorophore concentration with time can be written as
d
dt
rF0s “ kFonrF´srH`s ´ kFoff rF0s (4.17)
and
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d
dt
rF´s “ ´kFonrF´srH`s ` kFoff rF0s. (4.18)
Note that there is no term for permeation through bilayer since molecules are unable
to permeate.
Obviously, it will the affect proton concentration with an addition to the equation
(4.13). Resulting rate equation of proton is
d
dt
rH`i s “ ´konrD0i srH`i s ` koff rD`i s ´ kFonrF´srH`s ` kFoff rF0s ` kH`∆cH` . (4.19)
Model 2a In model 1, we assumed permeation of charged drug has no effect on pH since
its permeation is too slow. In this model, the third term in equation (4.15) is introduced.
Model 2b Introducing permeation of charged drug changed pH profile (see Results),
resulting a different curve from experimental data ([55] Figure 2b). Since membrane
potential may be the factor blocks permeation of charged species into the bilayer, it is
introduced into the model.
The current carried by an ion S can be calculated via multiplying permeability, PS ,
with nonlinear function of voltage. Goldman-Hodgkin-Katz (GHK) current equation [57,
58] yields,
IS “ PSzS V F
RT
rSis ´ rSosexpp´zSFV{RTq
1´ expp´zSFV {RT q , (4.20)
where zS is charge of S, R and F are gas and Faraday constants, T is temperature. And
V is the membrane potential which is denoted in GHK voltage equation
V “ RT
F
ln
ˆřPcrcationos `řParanionisřPcrcationis `řParanionos
˙
, (4.21)
where rcationos, rcationis, ranionos and ranionis are concentrations of cations and an-
ions at outside and inside of the vesicle, respectively. Pc and Pa are permeability coeffi-
cients of cations and anions in the system.
By implementation of membrane potential into rate equations of charged dyclonine
and proton (equations (4.15) and (4.19)) gives
d
dt
rD`i s “ konrD0i srH`i s ´ koff rD`i s ` kD`V
rDo` se´V ´ rD`i s
1´ e´V (4.22)
and
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d
dt
rH`i s “ ´konrD0i srH`i s`koff rD`i s´kon FrF´srH`s`kFoff rF0s`kH`V
rHo` se´V ´ rH`i s
1´ e´V ,
(4.23)
where
V “ ln
ˆPD`rDo` s ` PH`rHo` s
PD`rD`i s ` PH`rH`i s
˙
. (4.24)
Note that RT {F in calculation of potential, V , will be canceled when it is imple-
mented in the current equation. Therefore they are not rewritten in equations (4.22),
(4.23) and (4.24) for simplicity.
Model 3 As system also includes Cl´ and Na` ions, they are also introduced into the
system. Ion concentration is 20 mM in the studied experiment, so initial concentrations
of ions in the vesicle were set to 20 mM (rNa`i st“0 “20 mM, rCl´i st“0 “ 20 mM) and
outside ion concentrations were kept constant (rNao` s “20 mM, rClo´ s “ 20 mM).
Since the membrane potential is effected when ions are introduced into the system,
voltage should be expressed as
V “ ln
ˆPD`rDo` s ` PH`rHo` s ` PNa`rNao` s ` PCl´rCl´i s
PD`rD`i s ` PH`rH`i s ` PNa`rNa`i s ` PCl´rClo´ s
˙
. (4.25)
Rate equations of charged dyclonine and proton are same with equations (4.22) and
(4.23) with modified voltage expression (4.25). And as Na` and Cl´ ions are capable
of permeate the bilayer even though their permeability coefficients are extremely low, we
write rate equations of ions inside of the membrane as
d
dt
rNa`i s “ kNa`V
rNao` se´V ´ rNa`i s
1´ e´V (4.26)
and
d
dt
rCl´i s “ kCl´p´V q
rClo` seV ´ rCl´i s
1´ eV , (4.27)
where kNa` and kCl´ are permeability rates of Na` and Cl´ ions calculated via (4.5)
where PNa` and PCl´ are permeability coefficients which are taken as 10´14 cm s´1 and
10´11 cm s´1, respectively [59].
4.3 Results
First, initial 0.5 s of pH profile was analyzed via the models that are explained above.
Model 1a As initial model, there are only proton, charged and neutral drugs present in
the vesicle and only neutral drug can permeate through bilayer. In Figure 4.1, we see that
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within 0.2 s pH reaches equilibrium.
 time (s)
0 0.1 0.2 0.3 0.4 0.5
 
pH
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6.1
6.3
6.5
6.7
6.9
Figure 4.1: pH increases with time and saturates around t = 0.2 s which is consistent with
experimental data.
Figure 4.2 shows that concentration of charged drug is also saturated within 0.2 s and
neutral drug is saturated in 10 µs.
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Figure 4.2: Charged (black), neutral (red, inset) drug concentration change over time.
Note that neutral dyclonine concentration reach to equilibrium in 10 µs.
As equilibration of neutral drug occurs in µs scale, it is plausible to keep rD0i s “ rD0os
which effects equilibration of neither pH nor charged drug (Figure 4.3).
For this system, rate equations for rD`i s and rH`i s can be written as«
rD`i s
rH`i s
ff
“
«
´koff konrD0i s
koff ´konrD0i s
ff«
rD`i s
rH`i s
ff
,
Eigenfunction of the matrix is p1,´1q and corresponding eigenvalue is ´pkoff ` konrD0i sq
that gives the rate of exponential function.
In addition, it is also possible to predict weighting coefficient of exponential function
(A), which is the saturation point of rD`i s. Note that in the equation (4.10), rD`i s “ 0,
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Figure 4.3: pH and neutral drug concentration profiles when neutral drug concentration is
kept constant
rD0i s “ rD0os which is constant and rH`i s “ 10´pH at t “ 0. At equilibration, rD`i seq “ x ,
rD0i seq “ rD0os and rH`i seq “ 10´pH´x where x is the saturation concentration of charged
drug. As,
Kd “ rD
0
i seqrH`i seq
rD`i seq
“ rD
0
osr10´pH ´ x s
x
(4.28)
resulting,
x “ 10´pHrD0os{pKd ` rD0osq. (4.29)
So as we know both rate, ka “ konrD0s ` koff , and weighting value, A “ x “
10´pHrD0os{pKd ` rD0osq we are supposed to predict pH change over time.
Model 1b Note that this is a monoexponential function which is not consistent with
experimental results reported in the study of Eyer et al.[55]. There is also a fluorescence
molecule (HPTS) in the vesicle which has an ionizable side chain at pKa “ 8.5. Hence,
we introduced the fluorescence molecule into the systems as described in the equations
(4.17), (4.18) and (4.19). Resulting change in the pH is shown in the Figure 4.4.
Here it is seen that there is a second time scale (which is not detected in Figure 4.1)
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Figure 4.4: Fluorescence molecule introduces the second exponent in pH profile.
as a result of contribution of the fluorescence molecule.
Model 2a In order to see whether permeation of charged drug affects the internal pH,
we simulated the system after letting charged molecule and proton penetration into the
vesicle. Resulting system is shown in Figure 4.5.
 time (s)
0 0.1 0.2 0.3 0.4 0.5
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Figure 4.5: pH decreases back to its initial value in a short time when charged drug and
proton permeabilities are introduced to the system.
As it is seen in the figure, introducing the charged drug permeation into the system
provides reaching back to the initial pH value in a short time. The reason is when charged
drugs are internalized into vesicle they become a proton source to the vesicle which pro-
vides recovery of the initial pH in just 0.2 s. Note that since the vesicle size is extremely
small, given pH corresponds to only a few H` ions. That is why the pH inside of the
vesicle is highly sensitive to permeation of charged drug. On the other hand, proton
permeability does not effect the result (data not shown) since both its permeability and
concentration are too small that can be said within the studied time scale it is difficult for
a proton to enter into vesicle.
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Model 2b As pH profile of the previous model is not consistent with experimental pH
profile, some other property should be added to the model which can inhibit internaliza-
tion of charged drug. For this purpose, membrane potential was introduced to the model
2a. Resulting pH profile is shown in Figure 4.6.
 time (s)
0 0.1 0.2 0.3 0.4 0.5
 
pH
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6.1
6.3
6.5
Figure 4.6: Membrane potential blocks permeation of charged drug which provides
achieving experimental results.
It is seen that introducing membrane potential blocks recovery of pH resulting pH
profile consistent with experimental pH profile.
Model 3 Since the medium of the experiment includes ions, Na` and Cl´ ion per-
meabilities were added to the simulation which may have effect on membrane potential.
Resulting pH profile is shown in Figure 4.7.
 time (s)
0 0.1 0.2 0.3 0.4 0.5
 
pH
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Figure 4.7: Addition of ions into the system changes the pH profile via changing mem-
brane potential.
Although it is difficult to distinguish Figure 4.7 from Figure 4.6, when pH profiles are
fit to equation (4.1), coefficients of the fits are changed (data not shown).
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As the researchers indicate by determining the fastest rate of exponential function, ka,
it is possible to determine permeability coefficient. However as we show in the model 1a,
the rate is only dependent on kon and rD0i s. When PD0 is multiplied and divided by three,
resulting fit parameters are given in 4.3.
PD0 (cm s´1) A ka (s´1) B kb (s´1) Papp (cm s´1) PD0 (cm s´1)
0.52 ´0.060 28.72 ´0.581 12.99 0.84 ˆ 10´4 0.33
1.55 ´0.068 31.19 ´0.57 13.18 0.91 ˆ 10´4 0.36
4.65 ´0.066 33.09 ´0.57 13.28 0.96 ˆ 10´4 0.38
Table 4.3: Coefficients of biexponential fits to simulations of different PD0 . Papp values
were calculated via equation (4.6) and PD0 values were calculated via equation (4.8).
Note that when we change the permeability coefficient of neutral drug on the order
of magnitude, calculated Papp (and so PD0) via equation (4.6) does not change linearly.
Therefore, this experimental approach to determine permeability coefficients should be
open to discussion.
On the other hand, as we change kon, ka also changes. The change of the pH profile is
shown in Figure 4.8. Resulting coefficients are given in Table 4.4. As it is seen in table,
there is a linear relation with kon and ka.
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Figure 4.8: Change of kon affects ka linearly.
kon (M´1 s´1) A ka (1/s) b kB (1/s)
1{3ˆ 1010 ´0.188 7.14 ´0.470 3.99
1010 ´0.415 18.53 ´0.285 6.840
3ˆ 1010 ´0.384 56.87 ´0.31 21.56
Table 4.4: Coefficients of biexponential fits to simulations of different kon.
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As it is seen changing kon affects the ka linearly. Ion concentrations are different from
previous analysis. Because for this kon analysis, higher values result a slight decay which
will be discussed below.
In the article, authors indicate they also analyze the fluorescence signal for longer
times and fit to four-exponential function which is stated in equation (4.9).
We simulated model 2b for 500 s, resulting pH profiles are shown in the Figure 4.9.
 time (s)
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Figure 4.9: When ions are not introduced into the system model 2b, pH never decreases
back to its initial value on the contrary of the experimental outcome.
It is seen that when ions are not in the system, pH in the vesicle remains constant.
Additionally, we simulated model 3 for 500 s with different ion permeaility coefficients
(black and blue) and fit it to four-exponential functions (red dashed).
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Figure 4.10: When pH profile is analyzed for longer time, it is seen that permeability
coefficients of ions are important in descending phase of exponential function. Changing
permeability coefficient of Cl´ ion order of magnitude affects pH profile drastically.
It is seen that for longer times, pH is recovered and reached back the initial value.
Coefficients of descending exponents of the four exponential functions changes as the
permeability coefficients of ions are changed. This shows that descending phases of pH
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profile in long time scale is dependent on ion permeability. In the article, it is stated
that pH recovery may be the result of proton leakage into the vesicle. However, chang-
ing proton permeability does not differ obtained coefficients of last two exponents of fit
function.
4.4 Discussion
In this chapter, we constructed a kinetic model with an increasing complexity to study
an experimental method which aims to measure permeability coefficients of some basic
ionizable drugs. It is shown that fastest rate of biexponential function does not report
permeability of the molecule. While it is almost non-sensitive to change in permeability
coefficient of the drug, it can be claimed that this phase is highly sensitive to protonation
rate, kon, of the drug. Moreover, it is possible to calculate kon with our simplest model,
model 1a.
Meanwhile, it seen that since the chosen fluorescence molecule is also ionizable, its
presence affects the pH profile that interferes with effect of the drug. This situation results
the second exponent on the pH profile in short term (0.5 s) (model 1b). Since it is not as
easy to determine kon as in the model 1a, chose of another fluorescence molecule which
is not ionizable could lead to determine kon of ionizable drugs with this experimental
method.
Additionally, we show that the reason of not seeing the effect of charged state is not
because its permeability coefficient is too small to permeate the bilayer in short time, but it
is the membrane potential which blocks permeation of charged species (model 2a, model
2b).
Since ions are also present in the medium, it is studied whether introducing them into
the simulation would effect the pH profile in the liposome. Even though effects of ions are
barely noticeable in short term (0.5 s), it is obvious that their permeabilities have dominant
effects on the pH profile in descending phases of the pH profile (500 s). It seems that it
may be possible to determine permeability coefficients of ions with the information of
descending phase rates (model 3).
Overall it is hard to confirm the apparent permeability coefficients of drugs that are
determined with this experimental model are the “real” values of permeabilities. In our
simulations, we see that change in permeability coefficients of neither charged nor neutral
states are effective in changing any rate of the exponents. In addition to drug permeabili-
ties, proton permeability also fails to lead any difference in rates.
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Chapter 5
Conclusion and Outlook
5.1 Conclusion
In this research, it was aimed to understand the permeability mechanism of an aliphatic
amine bearing drug, dyclonine, and its permeation through the lipid bilayer in atomistic
detail via molecular dynamics simulations. Since drugs which have aliphatic amines con-
stitute the largest subgroup of all drugs, revealing detailed information about drug-lipid
interaction and permeability of dyclonine is expected to provide insight about permeation
of many other drugs.
In second chapter, MD studies showed that dyclonine has different characteristic prop-
erties in both charge states. While both of the states were capable of entering into bilayer
spontaneously, only neutral drug was able to change leaflet. It was observed that during
entrance into the bilayer, molecule should approach with a specific orientation in order
to be able to succeed in insertion process, otherwise drug could penetrate into bilayer
partially and left the membrane in a few seconds. After insertion process was completed,
charged molecules failed to change leaflet because of the hydrophobic core of the mem-
brane. Once charged dyclonine entered into bilayer, it adhered its protonated part to
phosphate groups of phospholipid via electrostatic interactions and did not penetrate into
the bilayer core. On the other hand, once neutral dyclonine entered into bilayer it is
translocated several times without preferring any specific location along bilayer normal.
In third chapter, permeability coefficients of both charge states were calculated. For
this purpose, we needed to construct free energy and diffusion profiles along the bi-
layer normal. Complete profiles of free energy of both states were obtained via umbrella
sampling simulations. As charged dyclonine deformed membrane by drifting phosphate
groups and water molecules to the bilayer core, energy cost of locating the charged state
increased at the center of the membrane. On the other hand, molecule in neutral state
preferred to locate in the core of membrane.
Using two approaches to determine diffusion profile revealed consistent profiles. It
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was shown that both states have approximately same diffusion coefficient for each loca-
tion along the lipid bilayer normal. Overall profiles showed that diffusion coefficients
inside of the membrane is one order of magnitude lower compared to aqueous environ-
ment.
Permeation of the molecules were studied with three-layer perspective in order to un-
derstand how different structural compositions of bilayer impact permeation of the drug.
Since phospholipids have polar and non-polar regions, bilayer can be separated into three
layers with a non-polar region restricted by two polar layers. As molecules behave com-
pletely different in polar and non-polar regions based on their structure and physicochem-
ical properties, studying the permeation in three-layer view provided characteristics of
both charged states of the drug in different environments. We showed that while inser-
tion of both neutral and protonated dyclonine have same rate in insertion, the effect of
charge appears during translocation process. While neutral dyclonine can change leaflet
in nanoseconds, charged dyclonine is capable of completing this process in milliseconds.
In the dissociation step, it is seen that charged molecule is slightly faster than neutral
one. Overall, we saw that while neutral dyclonine is rather fast in permeation, charged
dyclonine is approximately 10´4 times slower.
Although there is no experimental study for determination of dyclonine permeability,
many other drugs are studied to measure their permeabilities via various experimental
techniques. One of these methods is the usage of pH sensitive markers as fluorescence
molecules. A recent study [55], focuses on permeability of aliphatic amine bearing drugs
and design liposomal fluorescence assay to measure permeabilities of a couple of drugs.
Kinetic models with increasing complexity were constructed to study this experimental
system in chapter 4. Results indicate that the parameter that they suggest as the “measure”
of the permeability is actually sensitive to proton binding rate rather than drug permeabil-
ities on the contrary of their claim. With a few modification to current system, it may be
possible to determine protonation rates of drugs and maybe permeability coefficients of
ions.
Overall, in this thesis we study drug permeation from atomistic detail to kinetic mod-
els. With these methodologies we are able to show characteristic behaviors of drug-lipid
interactions, determine permeability coefficients of a drug for both charged states and
model one of the experimental methods to determine drug permeability. The results we
obtained may be used to design new drugs and experimental techniques to determine per-
meabilities.
5.2 Outlook
In this study we focused on the mechanism of aliphatic amine bearing drugs, using the
same method one can study the second largest group of drugs, carboxylic acid bearing
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drugs.
Since liposomal fluorescence assay is not the unique method to measure permeabilities
of drugs, other methods can be modeled in order to understand their success in measure-
ment of the permeabilities.
Additionally, as the initial motivation was the “promiscuous synergism” of pentami-
dine, MD simulations can be performed to understand pentamidine-lipid interaction and
permeation though lipid bilayer. Actually, we had already started MD simulations of pen-
tamidine and preliminary studies show that when they span the membrane, they change
the thickness of it. However, it should be understood how pentamidine spans the mem-
brane and what is the energy cost for it. Therefore umbrella sampling simulations can be
performed for pentamidine.
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